CEO Healthcare Symposium
Alan J. Murray is president and CEO of Empire BlueCross BlueShield, an Anthem Company. Mr.
Murray possesses an in-depth knowledge of the healthcare industry and specifically the New
York market which greatly benefits our consumers, customers and provider partners in New
York. Prior to joining Empire, he most recently served as the founding President and CEO of
Northwell’s CareConnect Insurance Company, Inc., the first provider-owned commercial
insurance plan in New York State.
Preceding his career at CareConnect, Mr. Murray held the position of Vice President, New York
Market Lead at United Healthcare for more than four years and spent five years at Anthem
preceding that as Regional Vice President, New York Provider & Ancillary Network
Mr. Murray earned a Bachelor of Science degree in 2005 from Open University, Milton Keynes,
United Kingdom and served as a Second Officer in the British Merchant Navy for six years. He
lives in Syosset, NY with his wife and three children.
Barry H. Ostrowsky is the President and Chief Executive Officer of RWJBarnabas Health (RWJBH). RWJBarnabas Health has a service area that covers nine counties with five million residents. The system includes 11 acute care hospitals (five are teaching hospitals), three children’s hospitals, a pediatric rehabilitation hospital and its multiple outpatient facilities, ambulatory care centers, geriatric centers, a free-standing behavioral health center, New Jersey’s largest statewide behavioral health network, a satellite emergency department, trauma centers, comprehensive home care and hospice programs, pharmacy services, multi-site imaging centers, two accountable care organizations, as well as medical groups with primary and specialty care physician practices. The system is comprised of 33,000 employees (largest private employer in New Jersey); nearly 9,000 physicians (representing more than 40 percent of the state’s actively practicing physicians); and, 1,000 residents and interns. Mr. Ostrowsky is spearheading a system-wide endeavor to promote healthier living for employees and the members of our communities and develop an effective strategy to address the true social needs of our diverse communities.
The System and Rutgers University are forming New Jersey’s largest and most comprehensive academic health system. The public-private partnership aligns RWJBH, Rutgers, the State University of New Jersey, Rutgers Health and Rutgers’ education, research and clinical activities, including those at the Rutgers Cancer Institute of New Jersey -- the state’s only National Cancer Institute-designated cancer center -- and Rutgers University Behavioral Health Care. The partnership will result in a multi-specialty group comprised of more than 2,500 practitioners – one of the largest medical groups in the country. The alliance is dedicated to providing high quality patient care, leading edge research, and world-class health and medical education to transform and advance health care in New Jersey.
Mr. Ostrowsky joined Saint Barnabas Medical Center in 1991 as Executive Vice President and General Counsel and served in the same role when Barnabas Health was created in 1996. At Barnabas Health, he became President and Chief Operating Officer in 2010 and President and Chief Executive Officer in 2012. In April 2016, with the merger of Barnabas Health and Robert Wood Johnson Health System, he assumed his present position.
Among active memberships, Mr. Ostrowsky serves on the Boards of PSEG; the New Jersey Chamber of Commerce; Public Media NJ, Inc., operator of NJTV; and New Jersey Performing Arts Center. He is a member of the American Hospital Association (AHA) Health Care Systems Governing Council.
Mr. Ostrowsky was named to the 2018 ROI-NJ Influencers Power list and the 2018 NJBIZ Power 100 list. In 2016, NJBIZ named him the Executive of the Year in Business in New Jersey, and in 2017 he was named once again to the NJBIZ Health Care Power 50 list of the most powerful people in New Jersey health care, and to the Power 100 list, which includes the state’s most influential people in business. Previously, he had been named by Becker’s Hospital Review as one of its “300 Hospital & Health System Leaders to Know.” Mr. Ostrowsky received a BA from Rutgers University and a JD from the University of Tennessee School of Law.
Bea Grause began her tenure as President of the Healthcare Association of New York State (HANYS) on July 1, 2016 after serving as President and Chief Executive Officer of the Vermont Association of Hospitals and Health Systems for 14 years. In that position, she successfully led Vermont hospitals through a variety of reform initiatives, including the state’s single-payer debate, continuously and intentionally building the hospitals’ brand as trusted, competent leaders.
Bea completed a three-year term (2012 to 2015) as an at-large member of the American Hospital Association (AHA) Board of Trustees, including a 2015 term on the AHA Executive and AHA CEO Search Committees. As part of her AHA Board responsibilities, she also served as chairman of the AHA Allied Advisory Committee on Medicaid.
Before moving to Vermont, Bea worked for ten years in Washington D.C. in a variety of positions. She began her D.C. tenure as a Legislative Assistant; first in the Office of U.S. Representative Norman Y. Mineta and then for U.S. Representative Joseph P. Kennedy II. After she left Capitol Hill, Bea simultaneously held senior governmental affairs positions with the Tennessee Hospital Association and Massachusetts Hospital Association. She spent the last three years working as counsel with the law firm of Foley, Hoag. In this role, she developed tailored legislative and regulatory strategies for many healthcare clients.
Before coming to Washington D.C., Bea spent ten years in California. She worked as a registered nurse, primarily in the emergency room and intensive care areas at Santa Clara Valley of California. During this time, she earned her Juris Doctorate in 1991 from Santa Clara University School of Law.
Bea earned a Bachelor of Science in Nursing from Boston College in 1979 and is currently a Fellow of the American College of Healthcare Executives. She is also a 2003 graduate of the Vermont Leadership Institute.
Michael J. Dowling is president and chief executive officer of Northwell Health, which delivers world-class clinical care throughout the New York metropolitan area, pioneering research at the Feinstein Institute for Medical Research and a visionary approach to medical education highlighted by the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the School of Graduate Nursing and Physician Assistant Studies.
Northwell Health is the largest integrated health care system in New York State with a total workforce of more than 66,000 employees — the state’s largest private employer. With 23 hospitals, 6,675 hospital and long-term care beds, more than 665 outpatient physician practices and a full complement of long-term care services, Northwell is one of the nation’s largest health systems, with $11 billion in annual revenue.
Prior to becoming president and CEO in 2002, Mr. Dowling was the health system’s executive vice president and chief operating officer. Before joining Northwell Health in 1995, he was a senior vice president at Empire Blue Cross/Blue Shield.
Mr. Dowling served in New York State government for 12 years, including seven years as state director of Health, Education and Human Services and deputy secretary to the governor. He was also commissioner of the New York State Department of Social Services.
Before his public service career, Mr. Dowling was a professor of social policy and assistant dean at the Fordham University Graduate School of Social Services, and director of the Fordham campus in Westchester County.
Mr. Dowling has been honored with many awards over the years. They include: his selection as the Grand Marshal of the 2017 St. Patrick's Day Parade in New York City; induction into the Irish America Hall of Fame; the 2012 B’nai B’rith National Healthcare Award, the Ellis Island Medal of Honor, the 2011 Gail L. Warden Leadership Excellence Award from the National Center for Healthcare Leadership, the 2011 CEO Information Technology Award from Modern Healthcare magazine and the Healthcare Information and Management Systems Society, the National Human Relations Award from the American Jewish Committee, the Distinguished Public Service Award from the State University of New York’s Nelson A. Rockefeller College of Public Affairs and Policy, an Outstanding Public Service Award from the Mental Health Association of New York State, an Outstanding Public Service Award from the Mental Health Association of Nassau County, the Alfred E. Smith Award from the American Society for Public Administration, and the Gold Medal from the American Irish Historical Society. For 11 consecutive years, Modern Healthcare has ranked Mr. Dowling on its annual list of the "100 Most Powerful People in Healthcare." In March 2016, Mr. Dowling was also listed No. 1 on Long Island Press’ 2015 “Power List” recognizing the 50 most-influential Long Islanders.
Mr. Dowling is chair of the Healthcare Institute and the Institute for Healthcare Improvement (IHI). He is a member of the Institute of Medicine of the National Academies of Sciences and the North American Board of the Smurfit School of Business at University College, Dublin, Ireland. He also serves as a board member of the Long Island Association. He is past chair and a current board member of the National Center for Healthcare Leadership (NCHL), the Greater New York Hospital Association (GNYHA), the Healthcare Association of New York State (HANYS) and the League of Voluntary Hospitals of New York. Mr. Dowling was an instructor at the Center for Continuing Professional Education at the Harvard School of Public Health.
Mr. Dowling grew up in Limerick, Ireland. He earned his undergraduate degree from University College Cork (UCC), Ireland, and his master’s degree from Fordham University. He also has honorary doctorates from Queen's University Belfast, University College Dublin, Hofstra University, Dowling College and Fordham University.
As Brigham Health's Chief Information Officer, Adam Landman, MD, MS, MIS, MHS, will be responsible for maintaining a focus on excellence while developing system-wide strategic IT initiatives, with the goal of evolving the next generation of information systems across the BH enterprise. Landman is board certified in Emergency Medicine and Clinical Informatics.
He joined BWH in 2010 as director of Clinical Information in the Department of Emergency Medicine, where he led the project to move BWH ED clinicians from paper-based to electronic documentation. He also led the team that built the CliniCam mobile app, a secure and convenient image sharing app for acquiring digital images and storing them in the electronic health record, which was made available for all clinical users in the hospital. He previously served the hospital as the chief medical information officer for Health Information Innovation & Integration, where he oversaw a range of BH PeC responsibilities, such as the local implementation of the Sunquest laboratory information system and integration with Epic, with a novel positive patient identification specimen collection solution that has reduced laboratory specimen errors for inpatients. He had also been driving efforts at both the local and industry levels to improve the experience of hospital patients and visitors, strengthening the innovation culture at BWHC through programs like the Innovation Hub, and collaborating with external digital health companies and start-ups.
Landman received his MD from the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School and trained in Emergency Medicine at UCLA Medical Center. He was a Robert Wood Johnson Foundation Clinical Scholar at Yale University, where he also received his masters of Health Sciences. He completed graduate degrees in Information Systems and Health Care Policy and Management at Carnegie Mellon University.
Alan Dubovsky is the Chief Patient Experience Officer for Cedars-Sinai Health System in Los Angeles, California.
In his role, Alan is responsible for all patient experience strategies and associated operational improvements. His scope covers all service areas of the medical center including inpatient, ambulatory, emergency, and ancillary services.
Alan joined Cedars-Sinai in November 2016, with 15 years experience dedicated to improvement of patient experience in healthcare.
Prior to joining Cedars-Sinai, Alan served as the Director of Operations at Emory Healthcare in Atlanta, Georgia. In that role, Alan was responsible for the departments of Patient Experience, Physician Engagement, Special Constituent International Patient Programs, Referral Management, Education and Training, Leadership and Talent development.
Alan completed his undergraduate degree in Business Administration at the University of Georgia and his Executive Masters degree in Business Administration at Emory University.
Alex focuses on investments in the biopharmaceuticals industry, especially in pharmaceuticals, generics, drug delivery and specialty pharma and biotechnology. He joined H.I.G. Capital as a Managing Director in January 2016. He currently serves on the board of directors for Leiter’s Pharmacy, Clarus Therapeutics, and Keystone Dental.
Prior to H.I.G., Alex was spent 13 years making similar investments at Thomas, McNerney & Partners. Previous board seats included Auspex Pharmaceuticals (sold to Teva), InnoPharma (sold to Pfizer), Quinnova (sold to Amneal), Celator (public), Zogenix (public), Tranzyme (merged with Ocera) and observer roles at PCI Pharma Services (sold to Partners Group) and Coley Pharmaceutical (sold to Pfizer).
Prior to Thomas, McNerney, Alex spent 11 years in the research department at Hambrecht & Quist (and its successor firms Chase H&Q and JPMorgan). During his tenure at H&Q, Alex led research teams covering the biotechnology, specialty pharmaceuticals, large-cap pharmaceuticals, drug delivery and diagnostics industries. After the merger of Chase H&Q and JPMorgan, Alex became the firm’s healthcare strategist. He was named twice in The Wall Street Journal All-Star Analysts Survey, including his last year at JPMorgan in which he placed in all three categories: stock picking (#1 in pharmaceuticals), earnings estimate accuracy (tied for #2), and ‘home run’ hitting (#8 across all industries).
Alex is the co-chair of the Business Advisory Council of the Children’s Tumor Foundation, an advisor for the Partnership Fund of NYC, which manages a bioaccelarator to advance local healthcare research, and is on the Life Sciences Council for Springboard Enterprises, a group that assists women entrepreneurs. He is also a board member for the Greenwich Council of the Boy Scouts of America.
He graduated magna cum laude from Brown University, where he was elected to Phi Beta Kappa
Alina Moran is the Chief Executive Officer at NYC Health + Hospitals/
Metropolitan. Metropolitan is a 338-bed acute care facility located in East Harlem.
The hospital is member of NYC Health + Hospitals, the largest public health care
system in the nation, which provides essential services to 1.2 million New Yorkers
every year. In her current role, Mrs. Moran is responsible for leading the day-to-
day operations of the hospital, overseeing a $355 million dollar budget and over
Mrs. Moran previously served as Chief Financial Officer at NYC Health +
Hospitals/Elmhurst, where she oversaw a $570 million dollar revenue budget and
450 employees. At Elmhurst, she used Lean methodologies to significantly reduce
Discharged Not Final Billed (DNFB) and Accounts Receivable (AR) days, allowing
the hospital to capture revenue more efficiently. In addition, she served as the
Project Lead for the hospital’s implementation of EPIC, a leading electronic
medical records system. Prior to her time at Elmhurst, she served as the Assistant
Vice President of Managed Care, responsible for the negotiation, management
and implementation of the public health care system’s 18 managed care contracts
valued at $1.3 billion dollars. Over the years, she has been recognized for her
leadership in several key corporate initiatives including charge capture, revenue
optimization, documentation, and coding.
Mrs. Moran earned a Bachelor of Science in Mechanical Engineering from
Brown University and a Masters in Public Administration from Baruch College. She
is an active leader in her community and was involved in the establishment of the
Rhode Island Political Action Committee and Brown University Latino Alumni
Council. In addition, Mrs. Moran has been honored by the following prestigious
national organizations: Pew Civic Entrepreneurship Program (1998), National
Urban Fellowship Program (2000), National Hispana Leadership Institute
Executive Leadership Program (2008), America’s Essential Hospitals Fellows
Program (2013) and The Advisory Board Fellowship Program (2016). In 2017, she
was selected to serve on the Board of Trustees of New York Medical College.
Raised in the Bronx, Mrs. Moran now lives in New Jersey with her husband,
Robert, and two children.
Amy Perry is a strategic leader with an impressive background in finance and operations, clinical quality and academic medicine, and health policy and governance. She has earned an impressive reputation for identifying opportunities for growth and innovation with a focus on driving patient-centered care.
Amy oversees Atlantic Health System's six hospitals, including Morristown Medical Center, which has nationally-recognized programs and is currently ranked the top hospital in New Jersey by U.S. & World Report. She also develops and manages strategic growth initiatives for specialty service lines and more than 400 ambulatory and post-acute care service sites, creating additional points of access to connect with 1 million plus lives per year.
Formerly executive vice president of LifeBridge Health and president of Sinai Hospital, Amy was the driving force in launching Sinai Hospital’s BioIncubator, an innovation hub contributing to the growth of Maryland’s regional biotech community. Most recently, she oversaw the November 2017 rollout of Atlantic Health Advancements (AHa!), which is designed to not only encourage ideas and accelerate innovation, but also inspire our team of more than 16,500 employees and 3,700 physicians to enhance care delivery, improve clinical outcomes and reduce costs.
Amy has redefined the concept of growth by putting patients at the center and identifying the way hospital systems need to grow in order to best take care of those they serve. Her approach to tackling access and affordability has yielded surprising collaborations with those traditionally considered competitors. For example, Atlantic Health System’s recent partnership with MedExpress now serves as a model of how the health needs of a community can be better served when former competitors work together to coordinate care.
Making waves and breaking barriers is nothing new for Amy. In 2013, the Baltimore Sun named her one of their 50 Women to Watch and a local ABC News series featured her in a series on women advancing in the workforce. Amy is also a great example of a strong and compassionate female voice making an impact in health care and shaping the industry. Becker’s Hospital Review included her on their December 2017 list of 130 Women Hospital and Health System Leaders to Know (nationally) and NJBIZ named her one of the top health care leaders in New Jersey for 2018.
Amy earned her Bachelor of Arts degree in Communications from the University of Minnesota, and her Master of Science degree in Health Services Administration from Barry University in Miami.
Amy W. Schulman joined Polaris Partners in 2014, simultaneously assuming the role of Chief Executive Officer of Arsia Therapeutics, a Polaris-backed company acquired by Eagle Pharmaceuticals in 2016. In 2015, Amy co-founded Lyndra, Inc. with Dr. Bob Langer, where she is currently CEO. Amy is Partner of the LS Polaris Innovation Fund and represents Polaris investments as Executive Chair of SQZ Biotech and Olivo Labs.
Prior to these roles, Amy was responsible for leading Pfizer Inc.’s $4 billion Consumer Healthcare business, serving concurrently as Executive Vice President and General Counsel. Previously at Pfizer, Amy was SVP, President & General Manager of the infant formula and nutrition business where she was instrumental in the unit’s sale to Nestle for $11.85 billion.
Amy is the recipient of numerous awards and distinctions including: 2017 Boston Xconomy Newcomer Award; 2017 TedMed Speaker; Scientific American’s 2015 Worldview 100 List, Fierce Biotech’s 2014 Top 15 Women in Biotech, Fortune Magazine’s 2013 50 Most Powerful Women in Business, The American Lawyer’s 2013 Top 50 Innovators, and The National Law Journal’s 2013 100 Most Influential Lawyers in America.
Amy serves on the Boards of Directors of Alnylam Pharmaceuticals, Arsanis, Inc., Ironwood Pharmaceuticals and The Whitehead Institute. Additionally, she is a member of Harvard Business School’s Faculty where she teaches legal and corporate accountability. A Phi Beta Kappa graduate of Wesleyan University, Amy earned her J.D. from Yale Law School.
Dr. Andrew W. Brotman, senior vice president and vice dean for clinical affairs and strategy, chief clinical officer, is responsible for physician/hospital programmatic initiatives and ambulatory care. In these roles, he also leads the Faculty Group Practice, manages our partnerships with affiliate hospitals, including those in the NYC Health + Hospitals, and manages our faculty office complex. He is the executive sponsor of the oncology service line, and played a significant role in the opening and ongoing operation of the Clinical Cancer Center at 34th Street, now part of the Laura and Isaac Perlmutter Cancer Center. He also leads the cardiac and vascular service lines and other strategic clinical areas. Dr. Brotman is also a professor of psychiatry at NYU School of Medicine. He has been at NYU Langone Health since 1999 and was instrumental in leading the development of an infrastructure to manage the clinical enterprise over a period of significant growth.
Prior to NYU Langone, Dr. Brotman was senior vice president and chief operating officer for physician practice management and network development for CareGroup in Boston. In that position, he was responsible for the operations of employed physician practices, and was one of the founders of the managed care organization known as the Physicians Services Network. Dr. Brotman was also the chief of psychiatry at Beth Israel Deaconess Medical Center, and prior to that was chief of psychiatry at the Deaconess Hospital, where he also served as president of the medical staff and later as medical director of Pathway Health, a four-hospital network. He served as interim president of Mt. Auburn Hospital in 1998.
Dr. Brotman completed his psychiatry residency at Massachusetts General Hospital beginning in 1981 and had increasing levels of responsibility at that institution until 1991, when he went to Deaconess. He spent much of his time at Massachusetts General in a public-private partnership with the state, serving as director of public psychiatry for Massachusetts General and later as clinical director of the Eric Lindemann Mental Health Center.
He is on the editorial boards of several journals and has over 80 publications to his credit.
Dr. Andrew Louis Pecora graduated from Seton Hall in 1979 with honors, receiving a BS in Biology. He completed medical school in 1983, receiving an MD from the University of Medicine and Dentistry of New Jersey with honors. In 1986, he completed an internship and residency in internal medicine at the New York Hospital-Cornell Cooperating Hospitals System. Dr. Pecora then moved on to Memorial Sloan-Kettering Cancer Center and completed a fellowship in hematology/oncology in 1989, after which he moved to Hackensack University Medical Center initially to serve as Director of the Adult Blood and Marrow Transplant Program. He was promoted in 2001 to serve as Chairman and Executive Administrative Director of the Cancer Center at Hackensack University Medical Center. In 2012 he was promoted to Vice President of Cancer Services and Chief Innovation Officer, Hackensack University Medical Center. Dr. Pecora was recently promoted to President of the Physician Enterprise, Hackensack Meridian Health. He is founder and served as President of Regional Cancer Care Associates. Dr Pecora was promoted to Professor of Medicine, UMDNJ-New Jersey Medical School, in 2004 and in 2013 to Professor of Oncology and Medicine, Georgetown University.
Dr. Pecora is a Diplomate of the American Board of Internal Medicine, subspecialty of hematology and subspecialty of oncology. He has received numerous awards and honors including the Women’s’ Guild Premedical Academic Achievement Scholarship (1978), elected to Who’s Who Among Students in American Universities and Colleges (1979), the Academic Excellence Award in Biology (1979), and the Drs. Milton and Rose Prystowsky Award for overall excellence in patient care (1983). He was elected into Alpha Omega Alpha in 1982, received the Outstanding Teacher Award from the Department of Internal Medicine at Hackensack University Medical Center in 1989 and has been acknowledged by Castle and Connolly, New York Magazine and New Jersey Magazine as one of the Best Doctors in America and one of the best Cancer Doctors in America from 1997 to 2016. Dr. Pecora has also been acknowledged by Who’s Who in America (2005-2007), Who’s Who in medicine and health care (2004-2011) and the international Who’s Who of professionals (2002). He received the American Cancer Society Physicians in the Forefront Award (1997) and the Susan G. Komen Breast Cancer Foundation Award as a Hero in the fight against breast cancer (1998). He received the EBMT-ESMO Award at the International Conference on High dose chemotherapy in Breast and Ovarian Cancer in 2000. Dr. Pecora has been honored by the March of Dimes (2007), inducted into the Nutley Hall of Fame (2005) and given the distinguished citizen award by the Hackensack chamber of commerce for his contributions to research and patient care (2001). Dr. Pecora co-founded and served as Chairmen and Chief Executive Officer of Progenitor Cell Therapy, L.L.C.; a company focused on facilitating the transfer of laboratory breakthrough to clinical application and practice in cell therapies. He also co-founded and served as Chairman of Amorcyte, Inc. a biotechnology company developing cell therapies for cardiovascular disease. Dr. Pecora founded COTA a healthcare software analytic company focused on enabling value based care delivery and serves as Executive Chairman. He served on the board of Cancer Genetics and is chairman of the board of Tetralogics, Inc., a company developing small molecules to treat cancer. He cofounded and currently serves as President of Regional Cancer Care Associates, an integrated cancer care delivery company with over 100 oncologists. He has served on the Board of Directors of the American Society of Bone Marrow Transplant and Cytotherapy. He was a member of Accreditation Committee of the Foundation for Accreditation of Hematopoietic Cell Therapy. He was a member of the National Blue Cross and Blue Shield Quality Centers for Transplant Experts Panel. He is a fellow of the Academy of Medicine of New Jersey, a fellow of the American College of Physicians, a member of the American Society of Bone Marrow Transplantation, American Society of Clinical Oncology and American Society of Hematology. He has been a member of several NHLBI/NCI state of the science meetings in transplantation and stem cell therapies.
Dr. Pecora has been involved in numerous research projects in an effort in improve the outcomes of patients with cancer. His work includes the leading the international effort to standardize CD34 enumeration and working to develop the production of stem cell products that are free of contaminating malignant cells using technologies including CD34 selection and ex vivo expansion. In addition he led the effort to assess, first in man, the safety and efficacy of oncolytic viruses administered parentally. Dr. Pecora holds over 40 national and international patents covering the composition and use of bone marrow derived cells for treating cardiovascular disease. Dr. Pecora has led several national trials in the field of transplantation and has published numerous peer-reviewed articles and abstracts and has presented the results of his research at many national and international scientific meetings.
Dr. Pecora is married and has three children and currently resides in Rumson, New Jersey.
Anjali brings two decades of healthcare and technology experience as both an entrepreneur and executive, having started and run various software and services companies including Conformia Software, an enterprise Product Lifecycle Management company acquired by Oracle in 2009.
Prior to Mytonomy, Anjali served as Senior Technology Advisor and Entrepreneur in Residence (“EIR”) in the Obama Administration and at the US Food and Drug Administration (2011-2013). Anjali drove multiple groundbreaking transformations across federal government including co-leading the innovation pathway (a new high speed review process for highly innovative medical devices that have substantial public impact); the $10M Tricorder Competition (first mobile medical scanning device to self-diagnose multiple medical conditions) in conjunction with xPrize and Qualcomm; leading the implementation of Cloud First within FDA (CDRH) and the EOP; helping to implement the Affordable Care Act Policies at CMS/ CCIIO; and overseeing the design and deployment of the White House Correspondence System.
She has served on several boards including the Advisory Board of Silicon Valley’s Forum for Women Entrepreneurs and Executives, Aidan Montessori School, TiE-DC, and DC Metro’s Parent Encouragement Program (PEP). Anjali was a Springboard Fellow in 2001 and has won numerous awards for her work including FWEE Trailblazer, FDA Commissioner’s Award for Innovation, Excellence in Government Award for FDA’s Innovation Pathway, Top 100 Life Sciences Visionaries and Top 40 under 40 Washington Business Journal. She received her A.B in Public Policy from Duke University and her M.P.P. in Public Policy from Harvard’s JFK School of Government. In her spare time she enjoys playing with her children (ages 6 and 11), hiking, reading, musical theater and screen writing.
Annette M. Walker serves as president of City of Hope Orange County. City of Hope chose Walker, a nationally recognized health care executive, to drive the development and growth of a robust cancer network throughout Orange County, and a state-of-the-art cancer center in Irvine.
Walker comes to City of Hope from the nation’s second largest not-for-profit health system, Providence St. Joseph Health. She served as president of strategy for Providence St. Joseph Health and chief executive of St. Joseph Health. In 2017, she was named one of the top 25 women in U.S. health care by Modern Healthcare magazine. Walker was responsible for system-wide strategy, marketing and business development across the seven-state Providence St. Joseph Health system.
Among Walker’s many accomplishments was the development of wellness capability for both consumers and employers throughout Orange County. These centers focused on medical care, as well as services for helping people adopt healthy lifestyles, and were designed to reach people where they work and live.
In addition to the Modern Healthcare recognition, Walker was named one of Becker’s "130 Women Leaders to Know" (2018), Los Angeles Business Journal’s "Executive of the Year" (2017), Orange County Catholic Foundation’s Bishop’s Award winner for Exemplarily Business Integrity (2017) and Orange County Business Journal’s "Innovator of the Year" (2016).
She has a Master’s in Health Administration from University of Minnesota and Bachelor of Science degree from Loyola Marymount University, Los Angeles.
Arthur Schwabe is the co-founder of Premier Home Health Care Services, Inc. He has
over 27 years of financial and business management experience. Additionally, Mr.
Schwabe has extensive experience in acquisitions and measurable success in profit and
loss management, health plan operations, and business development/start-up projects.
Prior to the formation of Premier Home Health Care Services, Mr. Schwabe co-founded
Premier Staffing Group.
Mr. Schwabe is a member of a number of home care organizations and has previously
served on numerous Boards which include the NYS Health Care Council, NYS Home
Care Association, and the NYS Association of Health Care Providers.
Born and raised in New York, Mr. Schwabe has a Bachelor of Science degree in Political
Science from Albany State University.
Arun is the Founder and Executive Chairman of Quartet, a mission-driven technology company that partners with insurers and health systems to make mental healthcare more accessible and integrated into primary care.
Prior to founding Quartet in 2014, Arun serially built and invested in technology companies as a General Partner at Accretive. Accretive was behind launching several industry changing companies such as Accolade, R1, Fandango and others. He has also held roles at Palantir Technologies, McKinsey & Company, and The World Bank.
Arun received a Masters from the Harvard Kennedy School where he was a Reynolds Fellow for Social Entrepreneurship and graduated with honors from Duke University. He has been active in development efforts in India, including launching a social enterprise to improve value capture to farmers and creating a program within the Government of India to improve quality in the public healthcare delivery system. He is passionate about technology’s uses to fix our society’s biggest problems. Arun resides in New York City with his wife, Mrinali, and their son, Aarav.
As the Founder and CEO of Wellist, Ashley combines her passion for improving the lives of patients with deep experience in strategic planning and business development. While a Strategy Director at Philips Healthcare, Ashley defined corporate and business strategies across the company’s three major business groups: Imaging, Patient Care and Clinical Informatics and Home Health Solutions.
Founded in 2013, Wellist now works with Mass General Hospital Cancer Center, Beth Israel Deaconess Medical Center and UPMC Hillman Cancer Center, with combined patient populations of over 100,000.
Over the past 12 months, Wellist has received numerous awards including a Silver Stevie® Award for Company of the Year, selected for its exceptional growth and notable achievements in healthcare technology. Wellist was also awarded “Innovative Tech of the Year—Healthcare Tech” from the Massachusetts Technology Leadership Council (MassTLC). The award cited Wellist’s significant contribution in the area of patient data and healthcare insights. In addition, Wellist was named a Rock Health/ Top 50 in Digital Health “for making exceptional progress in driving resources, attention, and innovation toward a massively better healthcare system.” Wellist received the “Diversity Leadership Award: Start-Up” for demonstrating “leadership in diversity, having continually shown their commitment to hiring, supporting, and building diverse teams to tackle the most pressing problems facing healthcare today.” Wellist was chosen as a “50 on Fire” company which recognizes “the city’s inventors, disruptors, luminaries, and newsmakers”.
Ashley was also recently named a winner of Med Tech’s 40 under 40 Healthcare Innovators.
Ashley earned her BA from Colby College and an MBA from the Tepper School of Business at Carnegie Mellon University. She has also completed coursework at the Boston College Graduate School of Social Work.
Working with a team of nearly 150 Operational Excellence staff members and coaches across Cardinal Health, Owad is responsible for developing and implementing an enterprise approach to Operational Excellence at Cardinal Health, ultimately improving the value delivered to the company's customers.
In addition to his role as senior vice president, Owad also supports the extension of Operational Excellence external to Cardinal Health as the executive sponsor for the company's relationships with the Lean Enterprise Institute (LEI) Partner Program, the Healthcare Value Network, The Ohio State University Fisher College Center for Operational Excellence and the Conference Board Quality Council. During his tenure, Owad has held several positions within Operational Excellence and has served as the primary architect of the company's enterprise-wide deployment of Operational Excellence, which, over eight years, yielded significant improvements in customer loyalty, employee engagement, operational performance and working capital utilization.
Prior to joining Cardinal Health, Owad held several operations and administrative roles that have used the tools of Lean Six Sigma to transform health care provider organizations, supply chain and medical supply companies. These roles include corporate director of quality for ProMedica Health System, executive director for Cordelia Martin Health Center and several adjunct faculty positions with the College of Pharmacy at the University of Toledo and other nationally-recognized programs.
Owad is also active in the community, serving in the past as board chair for the Central Ohio American Red Cross BioMedical Services, board chair for Cordelia Martin Health Center, senior examiner for the Malcolm Baldrige National Quality Program, and examiner / team leader for the Ohio Award for Excellence. Currently, Owad serves as a board member for the Partnership for Excellence, Mid-Ohio Foodbank, and the ASHP Research and Education Foundation.
Owad received his bachelor's degree in pharmaceutical sciences and a master's of business administration degree from the University of Toledo. His post-graduate work includes the achievement of Fellow status with the American College of Healthcare Executives, multiple Lean Six Sigma certifications and continued development as a Lean leader though his work with Cardinal Health and LEI. Owad has also authored several publications and presentations on quality systems and customer loyalty.
Bob co-founded HEP in 2006. Prior to co-founding HEP, he was a Managing Member and co-founder of CB Health Ventures (“CBHV”) and its first and second investment funds beginning in 1997. Previous to CBHV, Bob spent three years as the President and COO of Harris & Harris Group, Inc., a publicly traded business development company, and ten years with Credit Suisse First Boston (now Credit Suisse).
Bob is a director of ContinuumRx and AllyAlign Health. He served as a director of Applied Pathways prior to its acquisition by AIM Specialty Health, a division of Anthem, Inc. He also served as a director of SCIO Health Analytics prior to its acquisition by EXLService Holdings, Inc.
Bob received a Bachelor’s and Master’s degree in Chemical Engineering from Massachusetts Institute of Technology and an MBA from Columbia Business School.
Bruce D. Greenstein joined LHC Group in 2018. As executive vice president and chief strategy and innovation officer, he leads the company’s value-based contracting, ACO management company, and alternative payment and delivery model strategies. He also oversees the company’s operations for technology and for the innovations business segments, as well as LHC Group’s healthcare vision initiatives. Mr. Greenstein previously served as chief technology officer (CTO) for the U.S. Department of Health and Human Services (HHS) in Washington, D.C. He has an extensive healthcare industry background in both government and the private sector, having served as president-west for New York-based Quartet Health, CEO of Blend Health Insights, and as managing director of Worldwide Health for Microsoft. Mr. Greenstein was a cabinet member in Louisiana, serving as secretary of the Department of Health and Hospitals. He also previously ran Medicaid-managed care and waivers and demonstrations at the Centers for Medicare & Medicaid Services (CMS).
Dr. Heller received her medical degree from Columbia University and a Masters of Business Administration from The University of Chicago. She has extensive professional experience within the pharmaceutical and healthcare industries and academic medical centers. As the Chief Scientific Officer at the Crohn’s and Colitis Foundation, Dr. Heller is responsible for all mission-related activities, including the research efforts and patient and provider support and education programs.
She previously worked for Weill Cornell Medical College, where she was Associate Dean of Intercampus and Industry Initiatives. In that role, Dr. Heller implemented plans to promote interdisciplinary collaborations between the medical school and Cornell University faculties, facilitated the development of an NIH-funded intercampus center, promoted collaborative research projects with industry partners, and managed the intercampus pilot grant program. Prior to Weill Cornell Medical College, she was at Athena Healthcare Consulting, working with industry and academic centers regarding new product opportunities, new drug development, and clinical and translational research. While there, she developed Models of Care, a health care information series that identified and described best practices in disease management.
In addition, Dr. Heller has experience in pharmaceutical drug development, including design and implementation of clinical development plans and involvement in new drug applications resulting in drug approvals. She has been published in more than 20 publications and is the recipient of the “Best Journal Article on Disease Management” honor.
Catherine “Kate” Mohr is Executive Vice President, Chief Nursing Officer for Guthrie. She is responsible for overseeing all nursing activities across the Guthrie system. Mohr joined Guthrie in 2016, bringing with her over 30 years of experience in nursing and nursing leadership positions. She received her Bachelor of Science in Nursing from the College of New Rochelle in New York, a Master of Science in Nursing from Duke University School of Nursing and a Doctorate of Nursing Practice from American Sentinel University. She is certified in Advanced Nursing Administration from the American Nurses Credentialing Center (ANCC).
When Chris Norwood founded Health People in 1990, it started out as a peer
educator-driven organization that supported women with AIDS. Today, Health
People's community peers help their neighbors navigate such conditions as
asthma and diabetes, drawing strength from shared backgrounds that can include
incarceration, substance abuse and limited education.
Health People with its array of successful peer programs and work with six PPSs (PerformingProvider Systems) is now at the cutting edge of state health transformation that seeks to coordinate effective grass-roots programs with improved clinical care and outcomes.
The South Bronx nonprofit has men's and family AIDS programs, and offers diabetes self-management and prevention, asthma self-care, smoking cessation and targeted outreach.
In the past three years alone, it has engaged more than 1,200 Medicaid patients with type 2 diabetes in the well evaluated Stanford Diabetes Self-Management Program. Before founding Health People, Norwood wrote about HIV/AIDS before there was wide recognition of the deadly epidemic. A pioneer in using peer education to enable communities to take control of their health, Norwood has been recognized internationally for her work in HIV/AIDS and peer-delivered health education. In 2018, she was named one of the 50 Most Notable Women in Health Care by Crain's New York Business.
Dr. A. Craig Hillemeier was appointed dean of Penn State College of Medicine, CEO of Penn State Health Milton S. Hershey Medical Center and Penn State Health System, and senior vice president for health affairs for Penn State University in July 2014.
Dr. Hillemeier joined Penn State in 2001 as chair of pediatrics and medical director of Penn State Children's Hospital. He served as interim executive director of the Medical Center for nine months during 2006 and subsequently became vice dean for clinical affairs at Penn State Health Milton S. Hershey Medical Center. He also served as director and chief operating officer of Penn State Medical Group since its inception in 2008.
Dr. Hillemeier oversaw the development and opening of the Children's Hospital in spring 2013. Under his leadership, the Children's Hospital has regularly scored greater than the 90th percentile on inpatient patient satisfaction surveys and has been named among the nation's best since 2010.
During Dr. Hillemeier's tenure as chair of pediatrics, faculty grew from 63 to 143 in 14 divisions. The newest division, Child Abuse Pediatrics, was formed in 2012 to support the Penn State Hershey Center for the Protection of Children.
As vice dean for clinical affairs, Dr. Hillemeier oversaw the growth of Penn State Medical Group to include nearly 900 physicians and 300 advanced practice clinicians, 64 specialty practices located at 24 clinics across central Pennsylvania, and more than 1,000,000 outpatient visits each year.
Dr. Hillemeier holds an undergraduate degree from the University of Iowa and earned his MD from Loyola University Medical School, where he then completed a residency in pediatrics.
Dr. Hillemeier is board-certified in pediatrics and pediatric gastroenterology and is immediate past chair of the American Board of Pediatrics.
Daniel Reingold, M.S.W., J.D. is President and Chief Executive Officer of RiverSpring Health, a leading non-profit senior care organization with a century of history and leadership, which includes the operation of the renowned Hebrew Home at Riverdale. Under Mr. Reingold’s tenure, RiverSpring Health has grown significantly to include a comprehensive suite of care solutions, from managed long-term care and assisted living, to rehabilitation services, senior housing and skilled nursing. As a passionate advocate for older adults, Reingold and his team opened the Harry and Jeanette Weinberg Center for Elder Abuse Prevention, the nation’s first elder abuse shelter. He serves on the boards of directors of the Continuing Care Leadership Coalition, the Greater New York Hospital Association and the Association of Jewish Aging Services. He received a B.A. from Hobart College, an M.S.W. from Columbia University, and a law degree from the Benjamin N. Cardozo School of Law of Yeshiva University.
Dr. Daphne T. Hsu is currently Professor and Interim Chair of the Department of Pediatrics at Albert Einstein College of Medicine, and Interim Physician-in-Chief at the Children's Hospital at Montefiore (CHAM). She is also Division Chief of Pediatric Cardiology and Co-Director of the Pediatric Heart Center at CHAM.
As Physician-in-Chief, Dr. Hsu oversees an integrated health system for children, providing comprehensive care at locations spanning primary care pediatrics and school-based health clinics, to surgical, neonatal and critical care inpatient units. There are 132 pediatric, 50 Neonatal Intensive Care and 74 nursery beds located at Montefiore’s three Bronx campuses.
With over 30 years of experience as a pediatric heart transplant cardiologist, Dr. Hsu is recognized throughout the world as an outstanding clinician and researcher who treats critically ill children with heart failure.
Dr. Hsu graduated from Harvard University and went on to receive her medical degree from Yale University. She completed her Pediatric Residency and Pediatric Cardiology training at the Babies Hospital of the Columbia Presbyterian Medical Center. Dr. Hsu’s main research efforts focus on improving outcomes in children and young adults with heart failure using medical and advanced therapies such as mechanical heart devices and heart transplantation. She has served in leadership positions in the American Heart Association, American College of Cardiology, International Society for Heart and Lung Transplantation, American Academy of Pediatrics, American Board of Pediatrics and is a member of the prestigious American Pediatric Society.
Mr. Lundquist joined Rome Memorial Hospital as its President/Chief Executive Officer in March 2016 bringing with him extensive experience as a trusted strategic thinker leading both small and large organizations through challenging transitions.
For nearly 25 years, Mr. Lundquist served as CEO of hospitals in Oklahoma, New Jersey, and most recently at the Health Alliance of the Hudson Valley in Kingston, NY, where he navigated three hospitals and two residential centers through a successful affiliation and system integration. In his early career, he developed his healthcare experience as a management engineer and a director of employee relations before transitioning into administration.
Mr. Lundquist earned his bachelor of science degree in industrial engineering at the University of Oklahoma and a master of business administration degree from Oklahoma City University.
Lundquist resides with his wife, Jane, in the Town of Lee. Married for 46 years, the couple raised three children and has six grandsons.
Desert Horse-Grant is the Senior Director of Research and Innovation for UCLA Health and helps inventors catalyze discoveries from the lab to the clinical environment. She partners with the UCLA Technology Development Group (TDG), campus leaders, accelerators, federal agencies, corporations, and startups to connect researchers to resources and opportunities for funding or commercialization opportunities. In 2019, she co-created UCLA Biodesign, a new yearlong innovation program, for early career fellows at the intersection of medicine, business and engineering with the goal of solving unmet medical technology or digital health needs. She launched a new UCLA Health Innovation Competition that not only offers opportunities for recognition and seed funding, but also helps to scale innovative patient experience and performance excellence efforts occurring in niche areas. In 2018, she launched a program that advises UCLA-affiliated start-ups on entry points for integration. In 2017, she helped faculty entrepreneurs by advocating the need to support the funding gap between academic research and commercialization. The TDG collaborated with Desert and colleagues from the David Geffen School of Medicine, the School of Engineering & Applied Science and the College's Divisions of Life Sciences and Physical Sciences to present the first campus-wide biomedical competition in order to advance novel therapeutics, medtech and digital health technologies. She’s a steering committee member for the FDA funded So Cal Consortium for Technology and Innovation in Pediatrics, which promotes and advances the commercialization of new devices. She’s an active member of the UCLA Data Governance Committee, and an advisory board member for UCLA Center for Smart Health. Previously at Fred Hutch (2013-2016), Desert was named 2015 Life Science Innovation Northwest Women to Watch by the Washington Biotechnology & Biomedical Association and named 15 Women to Watch by Disruptive Women in Health Care. Desert’s team created Oncoscope, a novel biotool chosen as one of two social impact projects by GitHub at their 2016 global conference. While at MSKCC (2000-2013) she helped create their first Brain Tumor Center and Neurosurgery Department. Concurrently, she was the Administrator and Education Director of a multi-million dollar NIH grant to create a Physical Sciences-Oncology Center and the Director of Education for an NIH grant for researchers at the intersection of computational medicine and cancer biology. Desert has been instrumental in driving cooperative scientific ventures and partnering with research teams to identify and advance findings from academia into everyday clinical use benefiting patients and transforming patient care.
Chief Executive Officer Donna Kelsey has years of experience in healthcare leadership, specializing in multi-site management, bottom line impact and continuous improvement. As CEO, she is responsible for driving strategic plans to carry out and protect the vision, mission and values of American Senior Communities.
Her goals include maintaining high levels of customer satisfaction through quality care and positive clinical outcomes, keeping ASC in compliance with federal and state regulations, and leading teams that drive total quality management processes that generate year-over-year profitability and growth.
Before joining ASC, Donna was president of the U.S. Division of Revera, a Canadian company; Executive Vice President of Operations for Kindred Healthcare, and a 26-year veteran of the U.S. Naval Reserve, where she achieved the rank of Captain. She holds a Bachelor’s of Arts degree in biology from Colgate University and a Master’s degree in Community Health from Old Dominion University.
Elliot Joseph, Chief Executive Officer of Hartford HealthCare, has championed the transformation of healthcare delivery to create efficient, high-quality, regional health networks. Throughout his career, Mr. Joseph has focused on reshaping healthcare organizations through the building of regional integrated delivery systems and creating and sustaining organizational cultures that reward innovation, accountability and engagement in service to patients and families.
Hartford HealthCare employs more than 18,000 staff members and generates $2.4 billion in net revenue. Prior to his arrival in Hartford, Mr. Joseph was president and CEO of St. John Health (SJH), a $1.8-billion southeast Michigan health care system. While there, he saw two SJH hospitals named to the top 15 of Thomson Reuters’ (formerly Solucient’s) Top 100 Major Teaching Hospitals in the U.S. SJH also was named one of Verispan’s Top 100 Health Care Systems, and one of AARP’s Top 50 Employers.
Mr. Joseph is chairman of Hartford HealthCare Indemnity Services LTD and is a member of the Connecticut Hospital Association Board of Trustees for which he chairs the Finance Committee. He also is a member of the Greater New York Hospital Association Board of Governors. He serves as the American Hospital Association State alternate delegate and is a member of Regional Policy Board 1. Other board memberships include the Metro Hartford Alliance and Hartford’s Bushnell Performing Arts Center. He recently was named “130 Nonprofit Hospitals and Health Systems CEOs to Know” by Becker’s Hospital Review and one of Hartford’s “50 Most Influential People.” He hosts a monthly radio show, “HealthCare Matters,” which focuses on the transformation of the American health care industry.
Mr. Joseph earned a master’s degree in health services administration from the University of Michigan in Ann Arbor and a Bachelor of Science from the State University of New York at Binghamton. He is an alumnus of the Wharton CEO Program for Healthcare Leadership. He is an American College of Healthcare Executives Fellow.
Emma DeVito, MBA, is President and Chief Executive Officer of VillageCare, a community-based, non-profit organization, serving people with chronic care needs, as well as seniors and individuals in need of continuing care and rehabilitation services. VillageCare provides care and services for more than 25,000 unique individuals annually through its residential and community programs and managed long term care plan MLTC. Ms. DeVito was extremely involved in VillageCare’s reconfiguration and reform of its long-term and chronic-care services, shifting the emphasis from nursing home care to community-based services and managed long-term care.
Today, VillageCare has expanded its services to more people than ever in community-based care. In 2012, VillageCare began operation of a Medicaid Managed Long-Term Care Plan, approved by the state Department of Health. In 2013, VillageCare was approved to participate in FIDA - a Fully Integrated Dual Advantage Demonstration Program. A Medicare Advantage Plan and a Special Needs Plan were also approved in 2017, and are currently operational. As of December 2018, total enrollment for all products exceeds 12,500 members.
The state-of-the-art VillageCare Rehabilitation and Nursing Center opened in 2010; it provides short-term rehabilitation and recovery in a unique patient-centered environment; annually the facility provides services to more than 1700 individuals.
Ms. DeVito's health care career – with a concentration in finance, management and strategic planning – spans more than 30 years. At VillageCare, her expertise and insight was essential to program growth and expansion, as well as new corporate ventures. Ms. DeVito serves on the boards of directors for: Continuing Care Leadership Coalition (CCLC) Chair; Greater New York Hospital Association (GNYHA) Vice-Chair Long Term Care; ACAP Association for Community Affiliated Plans; AmidaCare Vice-Chair (a Medicaid managed care plan for persons living with HIV/AIDS) and LeadingAge New York/Past Chair representing NY State.
Erica L. Rubinstein is the Vice President of Service Excellence and Patient Experience for Mount Sinai Health System (MSHS). Ms. Rubinstein is a passionate leader who works to align the mission, vision, and values of the health system around the patient experience. She works with key stakeholders to develop and align a system-wide patient experience data strategy, that focuses on looking at both patient and staff feedback in order to implement best practice interventions to improve the patient experience. Under Ms. Rubinstein’s leadership, the MSHS has transformed the way that staff addresses and responds to a patient/ family complaint or grievance by significantly reducing its response time while also utilizing a service recovery model that focuses on compassion and empathy. Her work also includes supporting the training and rollout of purposeful hourly rounding in partnership with our nursing leaders, and working in close partnership with the MSHS Office of Diversity and Inclusion (ODI). This partnership has been critical to the overall cultural alignment efforts centered on the patient experience and has included such projects as developing ADA training and awareness and enhancing the transgender patient experience. Ms. Rubinstein is a licensed clinical social worker (LCSW) in New York State and she is also a Certified Patient Experience Professional (CPXP).
Howard B. Gold is the Executive Vice President and Chief Managed Care Business Officer at Northwell Heath. Mr. Gold joined Northwell when the latter was the North Shore Health System in 1995 as Senior Vice President for Managed Care Services. At that time, providers were only permitted to negotiate pricing arrangements with Health Maintenance Organizations. In 1997, with the passage of rate deregulation and the advent of the merger of North Shore Health System with the Long Island Jewish Medical Center (forming NSLIJ), Mr. Gold became responsible for contract development and negotiations, with single signature authority for all NSLIJ assets and providers with third-party payers. Mr. Gold was appointed to his current role in 2013 where he holds primary strategic responsibility for relationships with all payers and for the development of value-based reimbursement mechanisms and payment terms for existing and new business ventures.
Mr. Gold also belongs to numerous Boards and regional and national professional associations including United Health Group’s Health Care Executive Leadership Council, Board Director for HealthFirst Insurance Company, Board Director for the Partners In Health Plan serving people with Development Disabilities, membership in HealthCare Financial Management Association, the National Institute for Healthcare Leadership and numerous other advisory groups and councils throughout the United States.
In 1993, prior to joining Northwell, Mr. Gold was appointed to the dual role of Vice President and Vice Provost at New York Hospital and Weill Cornell Medical School, responsible for strategic planning and the development of their managed care network. Before then, Mr. Gold was appointed in 1989 by Governor Mario Cuomo to the role of Executive Director of the Governor’s Health Care Advisory Board with the charge of articulating and disseminating policy and reimbursement reform initiatives for the State of New York. From 1978 through 1989, Mr. Gold held policy roles of increasing responsibility in the Office of Mental Retardation and Developmental Disabilities culminating in his appointment as Director of the Office of Policy and Planning in 1987.
Mr. Gold holds a Bachelor of Arts from the State University of New York at Buffalo and a Master of Arts from the Graduate Faculty, New School for Social Research. He has a diverse set of outside interests including literature, history, philosophy, painting and travel.
Iyah Romm is the CEO and co-founder of Cityblock Health, a care delivery and technology company spun out of Alphabet’s Sidewalk Labs which focuses on the hardest problem in healthcare—providing sustainable, cost-effective services to populations with the greatest needs.
Iyah founded Cityblock with the philosophy that people want—and deserve—more health, not more healthcare. In 2018, Cityblock launched a groundbreaking model of health and social care tailored to meet the complex health and social needs of those living in poverty. Cityblock’s model is powered by a technology platform purpose-built for low-income populations and designed in partnership with Medicaid-eligible New Yorkers.
Iyah is known nationally as an expert policymaker and practitioner in the field of transforming healthcare delivery and financing. He has drawn on his experiences in the public sector in leading Cityblock, a venture-based tech-enabled startup, and attracting to it a world-class leadership team.
Before Cityblock, Iyah was the Chief Transformation Officer at Commonwealth Care Alliance (CCA) in Massachusetts. There, he helped to steward nearly $1 billion in insurance premiums and care for tens of thousands of Medicaid and Medicare recipients. Iyah also played a significant role in Massachusetts’ healthcare reform efforts, holding leadership roles at the Health Policy Commission, the state Department of Public Health, and as affiliate faculty at Dr. Atul Gawande’s Ariadne Labs.
Iyah studied Biology at Brandeis University and medicine at Boston University before dropping out. He is usually found with his wife and two kids, either chasing garbage trucks in Brooklyn or sailing.
Dr. Jaewon Ryu is the Executive Vice President and Chief Medical Officer at Geisinger. He came to Geisinger from Humana, where he was President of Integrated Care Delivery and was responsible for Humana’s care delivery assets, a business segment with nearly $3 billion of revenue and comprised of owned and joint ventured clinic practices, as well as Transcend, a management services organization (MSO) assisting affiliated practices to adopt population health under value-based reimbursement methodologies.
Prior to Humana, he was the Chief Medical Officer at the University of Illinois Hospital and Health Sciences System. He has also previously held leadership roles at Kaiser Permanente, the Centers for Medicare and Medicaid Services, and as a White House Fellow at the Department of Veterans Affairs. He was also a practicing corporate healthcare attorney in the Los Angeles office of the firm McDermott, Will & Emery.
Dr. Ryu has served in various advisory roles including board positions with MCCI and JenCare, both being clinic/MSO organizations managing the financing and delivery of care for Medicare Advantage members under full-risk payment models. He has also served on the Board of Directors of the White House Fellows Foundation and Association.
Dr. Ryu earned his B.A. degree from Yale University and his M.D. and J.D. from the University of Chicago. He completed his residency training in emergency medicine at Harbor-UCLA Medical Center.
James E. Shmerling was named President and Chief Executive Officer at Connecticut Children’s Medical Center on October 1, 2015. Prior to joining Connecticut Children’s, Dr. Shmerling spent eight years as the Chief Executive Officer of Children’s Hospital Colorado, one of the top ranked children’s hospitals in the nation. For over three decades, Dr. Shmerling has served in management roles in children’s hospitals and is nationally recognized as a leader in issues concerning children’s health and wellness.
He earned his Bachelor of Science Degree in Health Education from the University of Tennessee in 1976. In 1980, he was awarded a Master of Science Degree in Hospital and Health Administration from the University of Alabama at Birmingham. He earned a Master of Business Administration from Samford University in 1984 and his Doctorate of Health Administration from the Medical University of South Carolina in 1999. Dr. Shmerling is a Fellow in the American College of Health Care Executives (ACHE). He is an adjunct faculty member in the Hospital Administration programs, University of Alabama at Birmingham.
Dr. Shmerling is a native of Nashville, Tennessee.
Jeffrey I. Farber, MD, MBA is President and Chief Executive Officer of The New Jewish Home. A specialist in geriatric medicine with extensive management experience, Dr. Farber came to Jewish Home from the Mount Sinai Health System, where he was Senior Vice President and Chief Medical Officer for Population Health, leading the quality, utilization, clinical integration, physician engagement, care management, and practice transformation efforts to drive performance in the System’s broad portfolio of value-based contracts. Dr. Farber was also Chief Executive Officer of Mount Sinai Care, LLC, the system’s Medicare Shared Savings Program Accountable Care Organization, which has more than 42,000 aligned Medicare beneficiaries.
Dr. Farber, who is board-certified in both Internal Medicine and Geriatric Medicine, has been an active clinician and educator. He serves as Associate Attending Physician in Geriatric Medicine at The Mount Sinai Hospital and Associate Professor of Geriatric Medicine at the Icahn School of Medicine at Mount Sinai, a position he retains now that he is at The New Jewish Home.
Dr. Farber’s research interests include models of care for older adults, population health management, and the clinical interface with healthcare finance. He is a nationally recognized speaker and has twice received federal grant funding through the U.S. Health Resources and Services Administration. Dr. Farber’s research has been published in The Annals of Internal Medicine, JAMA Internal Medicine, and The Journal of Hospital Medicine.
Dr. Farber holds an MD from Yeshiva University’s Albert Einstein College of Medicine and an MBA from the University of Massachusetts-Amherst. He lives in Tenafly with his wife and three children.
In the last 15 years, Jeffrey Le Benger, MD, FACS has navigated SMG’s dramatic transition from a small medical practice to a comprehensive, integrated delivery system with more than 600 providers, 70 locations, and 1.2 million annual patient visits. SMG’s coordinated model of care has simultaneously improved care for individuals, lowered costs of care, and improved care quality. Recognized for its consistent and progressive contributions to the state’s economic growth, SMG has been named one of New Jersey’s “50 Fastest Growing Companies” by NJBiz magazine for the last eight consecutive years.
Committed to medical leadership, Dr. Le Benger serves as Chairman of the Board of the Summit Medical Group Foundation (SMGF) a nonprofit 501(c)(3) foundation. Founded in 2013, SMGF’s mission is to enrich community members through health promotion, medical research and medical education.
Dr. Le Benger earned his medical degree from New York Medical College. He completed two residencies at Mount Sinai Medical Center in facial plastic and reconstructive surgery, and in otolaryngology, head and neck surgery, respectively. He is board certified in otolaryngology, head and neck surgery, and facial plastic and reconstructive surgery. Committed to high professional standards, Dr. Le Benger has achieved Fellowship status with the American College of Surgeons, American Rhinologic Society and American Society of Head and Neck Surgery.
Dr. Le Benger is the recipient of the MDx Medical, Inc. “Patients Choice” award and is featured in the New Jersey Family “NJ’s Favorite Kids’ Docs” listing. He has been recognized as a New Jersey Monthly “Top Doctor” for the last four consecutive years and is included on the 2015 NJBiz “Power 100” (No. 16) and the 2014, 2015 and 2016 “Power 50 in Health Care” lists, where he has been in the top 10 for the last two consecutive years. He was named Healthcare Professional of the Year by NJBiz in 2015, and was the EY Entrepreneur of the Year 2015 Award Winner in New Jersey.
Dr. Hagenkord is a board-certified pathologist with subspecialty boards in molecular genetic pathology and pathology/oncology informatics. As Chief Medical Officer, Jill is involved in health product strategy, identification and evaluation of strategic business partnerships, regulatory strategy, health information review, and the development of provider and patient support tools. She also serves as the company liaison to medical professional societies as an active member in the Association for Molecular Pathology, the College of American Pathologists, and the National Academies of Medicine’s Roundtable on Genomics and Precision Health. Jill received her M.D. from Stanford University School of Medicine in 1999, did residency training at the University of California at San Francisco and the University of Iowa, and completed fellowships at the University of Pittsburgh Medical Center. Subsequently, Dr. Hagenkord practiced pathology at Creighton University Medical Center where she founded iKaryo Diagnostics. Prior to joining Color, Jill was the Chief Medical Officer at 23andMe, Invitae, and Complete Genomics.
Joanne Mather Conroy, MD, was selected as the Chief Executive Officer and President of Dartmouth-Hitchcock and Dartmouth-Hitchcock Health by the Board of Trustees on June 14, 2017.
Dr. Conroy comes to Dartmouth-Hitchcock from a position as CEO of Lahey Hospital and Medical Center in Burlington, MA. In this role, she drove the clinical integration strategy for the hospital, expanded its educational and research programs and strengthened the organization’s operational infrastructure and facilities to support the overall objectives of Lahey Health.
Prior to her leadership role at Lahey, Dr. Conroy served for more than five years as Chief Health Care Officer for the Association of American Medical Colleges in Washington, DC. In this role, she advanced AAMC’s strategic imperative of leading change to improve the nation’s healthcare system. By working with member medical schools and teaching hospitals, Dr. Conroy helped establish national health priorities and developed best practices to improve health by focusing on medical education, care delivery, research, diversity and inclusion.
Prior to that, she served as Chief Medical Officer for four years, as Vice President, Academic Affairs for three, and Executive Vice president for three, at the Atlantic Health System based in Florham Park, New Jersey. The not-for-profit Atlantic Health System operates three acute care hospitals providing general medical and surgical services to residents of northern New Jersey. Its flagship Morristown Medical Center serves as a regional level 1 trauma center. While serving as Executive Vice President for the Atlantic Health System, Dr. Conroy was named president and chief operating officer for the Morristown Memorial Hospital (now called Morristown Medical Center) in Morristown, New Jersey.
Prior to these roles, Dr. Conroy held several academic and administrative leadership positions at the Medical University of South Carolina (MUSC). Among other responsibilities, she served as President of the MUSC medical staff, Director of Residency Education for the Department of Anesthesiology, Chair of the Department of Anesthesia & Perioperative Medicine, Associate Vice President for Medical Affairs, Executive Medical Director, and Senior Associate Dean of the MUSC College of Medicine.
She received her undergraduate degree in chemistry from Dartmouth College in Hanover, New Hampshire and was the recipient of a Robert Sloan scholarship from Singer Corporation. Dr. Conroy received her medical degree from MUSC, where she completed her residency in anesthesiology, serving as chief resident for one year.
Dr. Conroy is board certified with the American Board of Anesthesiologists, attained a Certificate of Added Qualifications in Pain Management, and is a diplomate with the American Academy of Pain Management.
A healthcare leader with more than 30 years of experience, John is highly focused on the company’s growth, operational, and innovation strategy. With an extensive background in hospital medicine, radiology benefits management, laboratory, pharmaceutical, health information technology, and entrepreneurial ventures, John has led several fast-growing companies, transformed existing business models into innovative value propositions, and managed finance and business development efforts for large healthcare companies. Prior to axialHealthcare, John served as CEO of Cogent Healthcare, Founder and CEO of National Imaging Associates, and CFO of the international division of a multibillion-dollar global pharmaceutical company based in Paris, now called Sanofi S.A.
John F. Rodis, M.D., M.B.A., is the eighth leader of Saint Francis, and the first physician to serve as President since its founding in 1897. Dr. Rodis previously served as Saint Francis’ Executive Vice President and Chief Operating Officer, Chief Physician Executive. Prior to his executive leadership roles, Dr. Rodis served as Chairman of the Department of Obstetrics and Gynecology and Physician Leader of the Women and Infants Service Line, a position he assumed in 2011.
Before joining Saint Francis, Dr. Rodis served as Senior Vice President for Medical Affairs and Chief Medical Officer at Stamford Hospital, where he also previously held the position of Chairman of the Department of Obstetrics and Gynecology. Prior to that, he was at the University of Connecticut Health Center, where he was the Obstetrics and Gynecology Residency Program Director, a member of the Division of Maternal-Fetal Medicine and Director of Perinatal Genetics.
Dr. Rodis received his medical degree from the Autonomous University of Guadalajara, Guadalajara, Mexico. He completed his residency in obstetrics and gynecology at St. Joseph’s Hospital and Medical Center, Paterson, NJ. He completed fellowships in Maternal-Fetal Medicine and Clinical Genetics at the University of Connecticut Health Center. He also recently received his Master of Business Administration from Rensselaer Polytechnic Institute. He holds the rank of Professor of Obstetrics and Gynecology at both the University of Connecticut School of Medicine as well as the Frank H. Netter MD School of Medicine at Quinnipiac University. He is a Fellow of the American College of Healthcare Executives.
Dr. Rodis is Board certified in Obstetrics and Gynecology and Maternal-Fetal Medicine. He is a Fellow of the American College of Obstetrics and Gynecology, and a member of the Society for Maternal-Fetal Medicine and the American College of Healthcare Executives. He is the author or co-author of over 100 papers published in peer-reviewed professional journals. He is a member of the Editorial Board for Connecticut Medicine, the medical journal of the Connecticut State Medical Society. He served as an oral examiner for the American Board of Obstetrics and Gynecology (ABOG) for 19 years. He currently serves on the Boards of the Connecticut Hospital Association (CHA) and the University of Saint Joseph.
Joseph E. Alhadeff, M.D. provides care for all types of orthopaedic problems with special expertise in primary and revision joint replacement of the shoulder, knee and hip. During his orthopaedic residency training, Dr. Alhadeff spent three months training at the Nuffield Orthopaedic Clinic in Oxford, England and one month staffing a ski injury clinic at Sugarbush Ski Resort in Vermont.
Dr. Alhadeff is recognized as a top performing provider in the Coventry Integrated Network 1. Coventry's Outcomes-based Network program (OBN) identifies healthcare providers who demonstrate a depth of experience in treating workers' compensation injuries and exhibit consistently better measures of clinical outcomes, medical utilization, pharmacy utilization, return to work and financial outcomes when compared to their peers.
Kathleen Kinslow is EVP & Chief Integration Officer of Thomas Jefferson University and Jefferson Health. Ms. Kinslow joined Aria Health in November 2010 as President and Chief Executive Officer (CEO). She previously served as CEO and Executive Director of Pennsylvania Hospital, part of the University of Pennsylvania Health System.
A Philadelphia native with more than 35 years of experience in health care, Ms. Kinslow began her career in nursing. A Certified Registered Nurse Anesthetist (CRNA), she holds a Bachelor’s degree in Education from Ottawa University in Kansas City, a Master’s degree in Education from St. Joseph’s University, a Master’s degree in Nursing from Temple University, a doctorate in Education from Widener University, and a Master’s degree in Business Administration from St. Joseph’s University. She was honored as one of the Top Fifty Business Women in Pennsylvania (2009) and is active in a variety of health care and nursing societies and organizations.
Kevin Dahill is president/CEO of the Suburban Hospital Alliance of New York State (SHANYS). The Suburban Alliance is the advocacy arm of the two regional hospital associations that Kevin Dahill oversees – the Nassau-Suffolk Hospital Council on Long Island and the Northern Metropolitan Hospital Association in the Hudson Valley. These two associations represent nearly 50 hospitals, which serve about 25 percent of New York’s population. A healthcare leader and policy expert and former hospital CEO, Kevin Dahill is routinely sought for his expertise on a variety of healthcare issues such as hospital economics and finance, health services planning, hospitals and community benefit, workforce issues, corporate compliance, quality and performance improvement, and managed care. He is a member of the American Hospital Association’s Regional Policy Board and serves on a variety of local and state advisory boards and task forces. He is a board member of the MBA Advisory Board at LIU Hudson. He holds a master’s degree in business administration from Fordham University and is a member of the American College of Healthcare Administrators and the American Association of Association Executives.
Dr. Kimberly Townsend is President and Chief Executive Officer of Loretto, a continuing care system located in New York, with assets in skilled nursing, housing, managed care, short-term rehabilitation and medical adult day services. She is also the author of "Lifecircle Leadership: How Exceptional People Make Every Day Extraordinary," a book that was released in Fall 2018.
Her dream was to go to El Salvador and report on its civil war, which led her to initially pursue a print journalism degree at Boston University’s School of Public Communication, but in her junior year, she dropped out of college, got married and started a family.
She was a stay-at-home mom for nine years, home-schooling her three daughters, and jokes about an initial aversion to schooling, which she eventually overcame. Finding herself in the position of being a single-mother, she ventured on an educational journey that today, is demonstrated in her receiving several degrees: a BS and MBA from the Whitman School of Management, her JD from Syracuse University College of Law, her MPA from the Maxwell School of Public Administration and most recently her Doctorate in Executive Leadership from St. John Fisher College.
Prior to joining Loretto, Dr. Townsend was the Associate General Counsel and Senior Director of Government Affairs for Welch Allyn, Inc. where she spent years successfully lobbying for healthcare reforms. She shares leadership lessons in the courses she teaches as an adjunct professor at the Whitman School of Management at Syracuse University, as well as the Syracuse University College of Law.
A champion for workforce development in Central New York, Dr. Townsend is currently a Governor’s Appointee to the New York State Workforce Investment Board. She also serves in various board leadership positions for a number of non-profit organizations, was a previous chair of the American Heart Association’s Go Red campaign and speaks nationally to organizations about leadership in Healthcare and innovating for the future.
She thrives on the energy of our 2,500 employees that provide care across the 19 facilities and programs of Loretto, and firmly believes that anyone in healthcare succeeds on a few key business measures: providing high value services to partners across the continuum at low cost and high quality, while delivering great patient experiences.
Lisa David is the President and CEO of PHS. She leads the organization in successfully providing public health services to underserved families and children, offering grants and management assistance to over 200 community-based organizations, and guiding public health research and evaluation. She also provides leadership in executing long-term strategies to address the public health needs of low-income communities throughout New York City.
Mark L. Wagar serves as President of Heritage Medical Systems, an affiliate of the Heritage
Provider Network and physician organizations. These advanced physician organization networks
serve over 1 million patient/members through integrated, population and value based health and
payment programs. Over 30,000 physicians in medical groups and independent practice
associations (IPA’s) in California, New York, and Arizona provide organized, accessible,
accountable care. The Heritage Provider Network and it’s affiliates, founded in 1979 by Dr
Richard Merkin, make up one of the nation’s leading physician-driven healthcare solutions
Mr. Wagar helps lead performance improvement and growth opportunities throughout Heritage
that can improve health, care, access and cost. On both the national and local level he is engaged
in health policy, educating elected and appointed officials and interest groups on fact based,
sustainable health policy change. A frequent public speaker on health issues, he regularly
represents Heritage with national and local media.
Previously Mr. Wagar served as the President and CEO of Empire BlueCross BlueShield based
in New York City. He has been an operating partner and advisor to private equity backed
healthcare firms, and held prior executive leadership roles in hospitals and other healthcare
At Empire BlueCross BlueShield, Mr. Wagar led New York’s largest health insurer covering
nearly 6 million people, and was a Senior Vice President in WellPoint, Inc. (now Anthem). At
Empire, he was engaged in an active leadership role in public policy, provider collaboration, and
community engagement. During his tenure, Empire achieved net growth of over 1 million
medical members, market leading member satisfaction results, strong overall operating results,
lower market costs for group and individual customers, and the introduction of the first major
medical home network in metropolitan New York.
An experienced officer and director in public and private organizations, Mr. Wagar currently
serves on the Boards of The New York Academy of Medicine, and TurningPoint. He has been
recognized as a Distinguished Alumnus of The Ohio State University, and a recipient of the Dr.
Jonas Salk Memorial Mentor in Medicine Award, as well as an honoree helping fund numerous
charitable causes supporting healthy communities and diversity. In 1971, he was a member of the
Big Ten Champion basketball team of The Ohio State University.
Matthew L. Primack serves as President of Advocate Christ Medical Center, a quaternary academic center of the Advocate Aurora Health system serving the southwest region of Chicago and its surrounding suburbs. His executive leadership role at the 800-bed Magnet Trauma 1 facility has been focused around safety, quality, and service while continuing the growth of key clinical institutes. Recognized as a Becker’s Top 100 Hospital, Top 8 Heart Transplant Program, and other national top ranking clinical programs, Primack prioritizes efficiency and excellence in operations, improved access for patients, and community partnerships.
Primack served as the Chief Operating Officer at Advocate Christ for two years prior to his current position. Before joining the leadership team at Advocate Christ, Primack served as the Vice President of Business Development and Clinical Institutes at Advocate Condell Medical Center where he was responsible for all strategic planning, mergers and acquisitions, clinical service lines, and physician alignment initiatives. He started his career by opening a private practice in the field of physical medicine and rehabilitation. His practice, which he opened in 2000, grew significantly over seven years of operation and was recognized by Crain’s Chicago Healthcare and Lake County’s Daily Herald for exemplary patient care and small business success. In addition to his clinical care and practice management, Primack launched a successful consulting firm dedicated to the growth and financial management of private medical practices.
Primack received his undergraduate degree from the University of Cincinnati in Pre-Medicine Biopsychology, a graduate degree from the Chicago Medical School in Physical Therapy, a clinical doctorate from Rosalind Franklin University of Medicine and Science in Physical Therapy and Rehabilitation, and a Masters in Business Administration from the University of Chicago. He completed the American Hospital Association’s Health Care Transformation Senior Fellowship and is an active member of the American College of Healthcare Executives. He has been appointed to the University of Chicago’s Booth School of Business Executive MBA Ambassador’s Board and is a 2016 Fellow of Leadership Greater Chicago.
Primack has a passion for the advancement and success of others, serving as a Healthcare Innovation Advisor to the University of Chicago and mentors graduate students and young careerists through opportunities and placement. He has been asked to advise on over 40 healthcare start-ups throughout the country and remains committed to the advancement of healthcare through innovation. Primack has lectured both regionally and nationally on the advancements of healthcare innovation and cost transformation. He serves on boards of several philanthropic and civic non-profit organizations throughout the Chicagoland area and remains committed to community improvement.
Mei Kong, RN, MSN has over 30 years of experience in healthcare. She is the Chief Operating Officer/Chief Nursing Officer at NYC Health + Hospitals/Coney Island, an acute care facility with 371 beds in southern Brooklyn. In her current role, she leads Nursing and Patient Care Services and is responsible for the day to day operations of the hospital. Ms. Kong formerly served as the Corporate Patient Safety and Employee Safety Officer at the Corporate office of NYC Health +Hospitals, the largest healthcare system in the nation serving 1.2 million New Yorkers, where she led 11 acute care hospitals, 6 diagnostic treatment centers, 4 long term facilities, and home health in patient and employee safety initiatives and programs. Under Ms. Kong’s direction, a wide range of strategic initiatives successfully targeted process improvements, patient and staff safety, engagement and wellness as well as culture change. She spearheaded program implementation and training of TeamSTEPPS, Just Culture, Disruptive Behavior Coaching, Patient Engagement/Involvement, Medication Safety, Nonviolence Crisis Intervention, Employee Wellness, and other clinical, patient and staff safety processes. Mei has presented locally and nationally on patient safety and nursing topics and is a published author in several peer reviewed journals including Gastroenterology Nursing, Clinical Simulation in Nursing and contributed to several other publications, including a chapter on medication error in the book “Patient Safety: A Case-Based Comprehensive Guide”. She was awarded the U.S. Army Dental Command Medal in Recognition Excellence and Professionalism, U.S. Army Medical Command Medal in Recognition for Excellence and U.S. Army Medical Department Regiment Award.
Michael A. Kasper is the chief executive officer of DuPage Medical Group (DMG), the largest independent, multi-specialty physician group in Illinois. In his role, he collaborates with DMG’s Board of Directors and leads the executive leadership team to set the business strategy and direct operations for the organization – with a goal of continuously delivering the highest quality, most accessible and compassionate healthcare to patients.
During his tenure as CEO, DMG has experienced unprecedented growth and expansion. DMG is now comprised of more than 700 physicians and 50 specialties in over 100 Chicagoland locations.
Under Kasper’s leadership, in August 2017, DMG announced a $1.45 billion investment from Ares Management Private Equity Group to enhance and support DMG’s growth initiatives, including population health, expansion into new geographies and opening new clinical lines of service to reach and treat more patients.
Prior to joining DMG in September 2010, Kasper was President of Humana Illinois. Kasper has also held executive roles with Coventry Healthcare, Aetna and Kaiser Permanente. In 2011, Kasper was named to Crain’s Chicago Business’ “40 Under 40” list for his superior business leadership and achievement in the Chicago area. In 2012, Modern Healthcare magazine recognized Kasper in its yearly “Up and Comers” list of honorees for his significant impact in the field of healthcare.
Kasper actively works with the Loeys-Dietz Syndrome Foundation (LDSF) to raise awareness of Loeys-Dietz syndrome, a genetic connective tissue disorder. He serves as a Board Member for the American Heart Association, where he was the 2008 and 2011 Co-Chair for the Chicago Heart Ball. He is also a member of the Chicagoland Chamber of Commerce Board of Directors and Associate Board Member of the Metropolitan Chicago Healthcare Council. He is also a member of the Economic Club of Chicago. He holds a Masters in Health Administration from Indiana University.
Michael Goldberg is executive director of LIJ Medical Center where he is responsible for day-to-day operations of the hospital’s 583 beds, 6,500 employees and 4,000 physicians. Working with the leadership team at LIJ, Mr. Goldberg is focused on driving clinical and operational initiatives to ensure appropriate, safe, efficient, innovative care to its patients.
As executive director, Mr. Goldberg focuses on operations, quality, finance, patient satisfaction and staff performance. He has been in progressive administrative roles at LIJ since 2009, including the hospital’s finance lead.
Before LIJ, Mr. Goldberg worked in Northwell's financial planning department for nine years, where he was responsible for capital planning, business plans and financial analytics.
Mr. Goldberg is also an adjunct professor in Hofstra University's Department of Health Professions, School of Health Sciences and Human Services, where he teaches graduate level students.
Mr. Goldberg received his Master of Health Care Delivery Science as part of the 2013 inaugural class from Dartmouth College. He holds a bachelor’s in business administration from the University of Rhode Island and an MBA in Finance from Hofstra's Frank G. Zarb School of Business.
Nick Desai is an accomplished and visionary entrepreneur who has started and led four venture-funded start-ups over the last 18 years. Nick is the Co-Founder and CEO of Heal, an on-demand doctor house call app available in Los Angeles, Orange County, San Francisco / Silicon Valley, San Diego, Washington D.C., and Northern Virginia.
For Nick, Heal is more than a company – it’s a mission to fix the broken $3 trillion healthcare system. Nick’s previous start-ups have been innovative leaders in technology-enabled fitness and weight loss, social media and mobile applications, and the web’s first self-updating address book. Nick earned his BS in Electrical and Computer Engineering from UC Irvine, where he is in the Engineering Hall of Fame, and an MS in Electrical Engineering from UCLA. Nick is on the board of the UC Irvine Alumni Association and the Los Angeles Chapter of the American Heart Association. In his occasional free time, he writes for the Huffington Post. Nick lives in Los Angeles with his wife and two little boys, who are his pride and joy.
Paige Dworak is the President and CEO of Prospect East Orange General Hospital, a 210-
bed, for-profit, safety net hospital serving the greater Newark area. East Orange is an
affiliate of Prospect Medical Holdings, a for-profit system of 20 hospitals headquartered in
Los Angeles, CA. As Chief Executive Officer, Ms. Dworak leads the organization in all areas
including hospital management, finances, and operations and sets the strategic
direction. Prior to becoming CEO, she held senior executive positions with Prospect at
Waterbury Hospital, Eastern Connecticut Health Network, and CharterCARE Health
Partners in Rhode Island.
Ms. Dworak has over 20 years of experience in hospital operations and financial
management. Prior to joining Prospect, she served in leadership roles at the Cleveland
Clinic, Trinity Health, and The Greater New York Hospital Association.
Ms. Dworak is board certified in healthcare management as a Fellow (FACHE) of the
American College of Healthcare Executives (ACHE) and serves as Immediate Past President
of the NY Chapter. She serves on the Board of numerous community and advocacy boards
including: the New Jersey Hospital Association, The Hospital Alliance of NJ, The Greater
Newark Healthcare Coalition, Lott Assisted Living Residence, Lott Community Home Health
Care, and The Healthcare Leaders of New York. She is a recipient several awards and
recognitions to include: the NJ Biz 40 Under 40 Award, the HELP Jamaica Medical Mission
Community Service Award, as well as a Service Award recipient from the American College
of Healthcare Executives. Ms. Dworak earned her Master Degree in Business
Administration (MBA) at Montclair State University, her Bachelors from William Paterson
University, and is Six Sigma Certified.
Paul Krakovitz, MD, is Associate Chief Medical Officer of Specialty Based Care at Intermountain Healthcare, an integrated, not‐for‐profit health system, based in Salt Lake City, Utah. He is part of a triad leadership team that oversees the delivery of care and operations for Intermountain’s 23 hospitals. Dr. Krakovitz is responsible for engaging more than 4,500 physicians as Intermountain transitions from fee‐for‐service‐based to value‐based care consistent with its mission of helping people live the healthiest lives possible.
In his current role, Dr. Krakovitz supervises hospital medical directors, as well as medical directors in six of Intermountain’s Clinical Programs, and medical directors for five hospital-based operating lanes. Prior to joining Intermountain in 2017, Dr. Krakovitz was vice chair of Surgical Operations for Cleveland Clinic. He also served as Section Head of Pediatric Otolaryngology in the Cleveland Clinic Head and Neck Institute, served on the children’s hospital executive committee and was an elected member of the clinic’s Board of Governors. He also held academic appointments at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve.
Dr. Krakovitz is a graduate of the Indiana University School of Medicine. He did residencies in otolaryngolgoy at the University of Vermont and Dartmouth Hitchcock Medical Center, and a fellowship at Cleveland Clinic. His current research and clinical focus is on improving value for specialty care. He serves on the audit committee for the American Society of Pediatric Otolaryngology and the Medical Education Committee for the State of Utah.
Mr. Healy, President of Beth Israel Deaconess Medical Center (BIDMC), has more than 25 years of experience in health care administration. Before joining BIDMC in January 2017, he served as President of Beth Israel Deaconess Hospital-Milton for four years. He has previously served as Chief Administrator of the Faculty Practice Plan and Vice President of Professional Services at Boston Medical Center and as Vice President of Medical Affairs and Clinical Services at Brigham and Women’s/Faulkner Hospital.
Mr. Healy earned his master’s degree in Healthcare Administration from Xavier University, Cincinnati, Ohio, and his bachelor’s degree at the University of Dayton, Dayton, Ohio.
As executive vice president and chief legal officer for Optum, Richard Mattera is responsible for all legal, regulatory and compliance activities.
Mattera joined UnitedHealth Group’s corporate legal team in 2012 with responsibility for the Securities, Transactions and International legal group. This group oversees the securities law compliance, capital markets, investments, real estate, M&A, joint ventures, key strategic transactions and international legal functions enterprise-wide. Mattera started at UnitedHealth Group in 2011 with Optum, providing legal support for M&A, joint ventures and key strategic transactions.
Prior to joining UnitedHealth Group, Mattera was a partner at the international law firm of Hogan Lovells and represented publicly and privately held companies in a variety of matters, including in the areas of M&A, joint ventures, securities, corporate finance and corporate governance.
Mattera earned his J.D. from The Ohio State University, Moritz College of Law and received his B.A. in political science from Pennsylvania State University, with high distinction. He currently serves on the Board of Directors of Twin Cities Habitat for Humanity.
Dr. Robert Galvin is Operating Partner of Equity Healthcare. Before joining Blackstone, Dr. Galvin was Executive Director of Health Services and Chief Medical Officer for General Electric, in charge of the design and performance of GE's health programs, including both health spending and the services delivered in its global medical clinics. Dr. Galvin is a nationally recognized leader in the areas of market-based health policy and financing, quality measurement and payment reform. Dr. Galvin is a member of the Institute of Medicine, a branch of the National Academy of Science, and sits on the IOM’s Board on Health Care Services. Dr. Galvin received his BA and MD from the University of Pennsylvania and an MBA from Boston University.
Mr. Glazer is responsible for the overall operation of ENT and Allergy Associates (ENTA) and focuses his attention on physician recruitment, mergers and acquisitions and strategic planning. Mr. Glazer is an ad-hoc member of all Board Committees and reports directly to the President of the group.
ENTA consists of over 200+ MDs in 42 locations in the NY/NJ metro region. He joined ENTA in December 1997 and has over 40 years of healthcare experience in finance and operations, information technology, managed care contracting, mergers and acquisitions, physician recruitment and healthcare marketing.
OASIS, Otolaryngology/Allergy Specialty Insurance Services, a self-funded self-insured Medical Malpractice Captive was formed by the partners at ENTA in 2008. Mr. Glazer serves as the Vice President/ Secretary of this Vermont domiciled insurance company. He has served on the Leadership Council as President - Association of Otolaryngology Administrators (AOA) and has participated on ad-hoc committees of the American Academy of Otolaryngology & Head and Neck Surgery (AAO-HNS). He is a Board Member of the Westchester County Association, a Fortune 500 business think tank.
Mr. Glazer is a Program Coordinator for the Healthcare Career Workshop Courses at Fordham University and an Adjunct Professor at Pace University Graduate Program for Public Administration - Health Policy and was recently reappointed to the NYS Ninth Judicial District BAR Grievance Committee for a 4 year term.
Prior to joining ENTA, Mr. Glazer worked as a hospital administrator at New York University Medical Center (1976-1985) where he was a Departmental Controller, Columbia Presbyterian Medical Center (1985-1993) where he served as the Treasurer, New York United Medical Center (1993-1996) where he was the Senior Director of Finance and Business Development.
Mr. Glazer transitioned to physician practice management in 1996 where he was the Vice President of Administration for ProHealth Associates, a multi-specialty sports medicine practice in Long Island.
Mr. Glazer has a BS in Business Administration from the State University of New York and a Masters in Public Administration & Health Care-New York University.
Robert A. Kasdin is the senior vice president, chief financial officer and chief operating officer for Johns Hopkins Medicine. He is responsible for overall finances and operations, including strategic direction, operations of existing programs, and development of new initiatives to ensure that Johns Hopkins Medicine's strategic imperatives are achieved or exceeded.
Kasdin came to Johns Hopkins from Columbia University, where he served as its senior executive vice president since 2002. He oversaw overall operations, finances, human resources, information technology, and development and commercialization of intellectual property. Additionally, he played an important role in Columbia’s relationships with major donors and with city and state government. While at Columbia, he also reorganized the university’s operations to integrate business processes and improved efficiency and accountability.
Before joining Columbia University, Kasdin served as the executive vice president and chief financial officer of the University of Michigan, treasurer and chief investment officer for The Metropolitan Museum of Art, and the vice president and general counsel for Princeton University Investment Company. He began his career as a corporate attorney at Davis Polk & Wardwell.
Kasdin earned his B.A. from Princeton and his J.D. from Harvard Law School. He is a board member for the Harbor Funds, Apollo Commercial Real Estate Finance, and the National September 11 Memorial and Museum. He previously chaired the board of trustees of the Dalton School and co-chaired the Transition Committee for New York City’s Comptroller. He is also a member of the Council on Foreign Relations.
Kasdin is married to Claire Ullman, a political scientist, and has three children.
Dr. Roy Beveridge joined Humana in 2013 as Chief Medical Officer. He is responsible for developing and implementing Humana’s clinical strategy, with an emphasis on advancing the company’s integrated care delivery model.
Dr. Beveridge is known for creating collaborative environments among physician communities and providing thought leadership around population health. He is a member of the Management Team, which sets the firm’s strategic direction, and reports to President and Chief Executive Officer Bruce Broussard.
Previously, Dr. Beveridge served as Chief Medical Officer for McKesson Specialty Health. Prior to McKesson’s acquisition of US Oncology in 2010, he served as the Executive Vice President and Medical Director at US Oncology. He has published extensively in the fields of medical oncology, stem cell transplantation, quality design and population health.
Dr. Beveridge earned a Bachelor of Arts degree from Johns Hopkins University and a medical degree from Cornell University Medical College. He completed his residency in internal medicine at University of Chicago Hospitals and his fellowship at Johns Hopkins Hospital.
Board certified in medical oncology and internal medicine, Dr. Beveridge has authored more than two hundred articles on a wide range of medical topics such as hematology, stem cell transplantation and quality standardization, and population health/value-based medicine.
Dr. Beveridge is a member of the American Medical Association, American Society of Clinical Oncology (ASCO) and the American Society of Hematology. He has served on many boards related to medical oncology and patient advocacy.
As chief executive officer of Magellan Healthcare, Sam Srivastava strives to improve the health and affordability of complex populations through clinical innovation driven by advanced analytics and agile technology. He leads the strategy, product development, operations, growth and profitability of Magellan Healthcare. Srivastava also provides enterprise leadership over strategy, marketing, communications, government affairs and the Magellan Cares Foundation.
Prior to joining Magellan, Srivastava worked at Cigna where he was president of the national and senior business segments. He had executive management responsibility for strategic planning, business operations, growth and financial performance for these segments, which serve approximately 18 million individuals. Srivastava also lead strategy and business development, where he was instrumental in the acquisition of HealthSpring, a Medicare Advantage health plan and MSO practice management company, and the strategic partnership with CatamaranRx, a pharmacy benefits manager.
Previously, Srivastava held executive leadership positions in the commercial, senior, low-income and disabled population business segments at UnitedHealth Group and HealthNet. He has also served as a management consultant in the United States and internationally, driving the integration of delivery systems and supporting providers, health plans and governments in managing population health.
Srivastava graduated from Kent State University with a bachelor’s degree in medical science and humanities, and completed graduate work at Yale University in healthcare management and policy. He sits on numerous advisory boards, including the Yale School of Public Health. He is married to Dr. Lisbet Lundsberg, an epidemiologist at the Yale School of Medicine, and resides in Wilton, Conn. with their four daughters.
Steve Narang, MD, was named CEO of Banner – University Medical center Phoenix in 2013.
Dr. Narang previously served as chief medical officer at Banner Children’s at Cardon Children’s Medical Center. Prior to Banner, he held several medical director and teaching positions in Louisiana, including medical director of graduate medical education and medical director of pediatric emergency services at Our Lady of the Lake Regional Medical Center in Baton Rouge.
He is founder and medical director of the American Academy of Pediatrics-Value in Pediatrics National Quality Improvement Collaborative Network. He also is a member of the executive board of the quality committee of the Arizona American Academy of Pediatrics Committee.
Sunny is Senior Director at the Partnership Fund for New York City, focusing on Digital Health, Fintech and Insurtech. Prior to the Partnership Fund, Sunny was Director of Strategy & Finance at RedVision (sold to First American). Previously, Sunny was an Investment Associate at Updata Partners focusing on growth-equity technology investments. Prior to Updata Partners, Sunny worked as an Investment Banking Associate at ThinkEquity Partners. He is a graduate of the Kelley School of Business at Indiana University.
Susan L. Solomon is Founder and Chief Executive Officer of The New York Stem Cell Foundation Research Institute, the world’s leading independent non-profit research institute dedicated to translating cutting- edge stem cell research into clinical breakthroughs and cures for patients.
A veteran healthcare advocate, Ms. Solomon serves on the boards of a number of prominent diabetes and regenerative medicine organizations including the College Diabetes Network and the Global Alliance for IPSC Therapies. She also serves on the Board of Directors of the Regional Plan Association. Ms. Solomon has received numerous awards for her work with NYSCF, including the New York State Women of Excellence Award from the Governor of New York, the Triumph Award from the Brooke Ellison Foundation, and recognition as a Living Landmark from the New York Landmarks Conservancy.
A lawyer by training and a chief executive and entrepreneur by experience, Ms. Solomon has decades of leadership experience in starting and building effective and focused organizations. Ms. Solomon started her career as an attorney at Debevoise & Plimpton, then held executive positions at MacAndrews and Forbes and APAX (formerly MMG Patricof and Co.). She was the founder and President of Sony Worldwide Networks, the Chairman and CEO of Lancit Media Productions, an Emmy award-winning television production company, and then served as the founding CEO of Sothebys.com, prior to starting her own strategic management consulting firm Solomon Partners LLC in 2000.
Dr. Susan L. Turney is the CEO of Marshfield Clinic Health System (MCHS), taking on that role
September 1, 2014. Through its entities, MCHS provides patient care, research, education,
health care technology and health insurance for Wisconsin and beyond.
She is recognized as a national thought leader in health care and expert in strategic planning,
executive management and external relations. She is sought out as a speaker by national
organizations to discuss the business of this industry and is a member of the Modern Healthcare
CEO Power Panel, including representatives of the nation’s largest hospital, physician practice,
insurer, trade association and think tank organizations. She was named to Modern Healthcare’s
list of 50 Most Influential Physician Executives from 2012-2016, 2018, and on its list of 100
Most Influential People in Healthcare in 2012- 2014. Dr. Turney received the Wisconsin
Medical Society’s Directors Award in 2017. She was named to Becker’s Hospital Review’s list
of 27 Female Physician Executives to know in 2018. She was also named Distinguished Leader
by MGMA-ACMPE in 2018.
Prior to her current MCHS position, Dr. Turney was President and CEO, Medical Group
Management Association (MGMA), the leading association for medical group practice
administrators and executives, from 2011-14. She was CEO and Executive VP of the Wisconsin
Medical Society from 2004-11. She is a Fellow in the American College of Medical Practice
Executives (FACMPE), having earned that distinction in 2005.
For 22 years, from 1982-2004, Dr. Turney was an internal medicine physician at Marshfield
Clinic, serving in education and leadership roles and as medical director for Patient Financial
Services from 1995 to 2004.
Dr. Turney, a native of Mellen, Wisconsin, graduated from Northland College, Ashland,
Wisconsin; and the University of Wisconsin-Madison School of Medicine and Public Health.
She completed her internal medicine residency at Marshfield Clinic/Ministry Saint Joseph’s
Hospital, Marshfield, Wisconsin, and earned a masters degree in administrative medicine from
With a focus on providing exceptional customer service and delivering the highest quality care, Sven Gierlinger is responsible for building an engaging, innovative and collaborative culture that drives organizational growth and customer loyalty through the customer experience.
He came to Northwell from the Henry Ford Health System in Detroit where he served as vice president, hospitality and service culture, responsible for creating a superior and consistent service experience for patients, visitors and employees. Mr. Gierlinger worked closely with leadership to drive culture change around improving the customer experience in every encounter across the system.
Prior to that, he was administrator, hospitality services, for Henry Ford West Bloomfield Hospital, responsible for all aspects of non-clinical operations, the Wellness & Integrative Health Center, retail shops and café, and the customer experience.
Mr. Gierlinger began his career in the luxury hotel business, holding a series of leadership positions with the Ritz-Carlton Hotel Company. He played a key role in the openings of several Ritz-Carlton hotels in Germany, Japan, Indonesia and the United States, responsible for executing and implementing Ritz-Carlton service standards, training staff and leading teams of trainers.
Mr. Gierlinger is a board member for The Beryl Institute and member of the Institute for Innovation, Founding Executive Council.
He received a bachelor’s degree in hospitality business administration from the Bavaria Hotel Management Academy, Altoetting, Germany.
Brett R. Friedman has experience advising a broad spectrum of clients on a variety of complex transactional, enforcement and regulatory matters within the health care industry. His clients include hospitals, managed care plans, pharmacy and dental benefit managers, pharmaceutical and device manufacturers and community-based providers of care to persons with mental illness and developmental disabilities. He routinely advises clients in responding to government investigations and audits concerning potential violations of health care fraud and abuse laws; maintaining regulatory compliance; and structuring innovative arrangements involving the development of integrated health care delivery networks in connection with value-based payment models.
Christopher J. Donovan is a partner with Foley & Lardner LLP. He focuses his practice on advising companies and their investors and lenders in mergers and acquisitions, recapitalizations, buyouts, and restructurings as well as advising on a broad range of commercial arrangements. Chris has particular experience in the health service, particularly post-acute, and life sciences sectors. He has a unique blend of deep regulatory as well as corporate and finance experience to bring to a transaction as a result of his consummating dozens of health and life science deals, both domestic and international. He is co-chair of Foley’s Health Care Industry Team, co-chair of the Post-Acute Care & Senior Housing Practice, and a member of the firm’s Private Equity & Venture Capital Practice.
Debra Richman is a Managing Director with Alvarez & Marsal Healthcare Industry Group in New York.
She brings deep expertise in driving revenue, developing and executing growth oriented strategic plans, forging accretive partnerships, new market & product development, and creating distribution channels for products and services across industry sectors; payers, providers, consumer health, digital health and retail medicine.
Ms. Richman advises a spectrum of healthcare industry clients, ranging from payors and providers to health systems, on best practices for developing and executing revenue growth plans, and driving superior financial performance.
Ms. Richman has served as an advisor to private equity and venture capital funds. She has counseled operating companies, from early stage and emerging market disruptors to mature market leaders in care delivery, healthcare system performance, and evolving delivery models. Ms. Richman provides strategic and tactical advisory services, including corporate and business strategies, go to market implementation, management support, and performance improvement.
Formerly, Ms. Richman was Chief Strategy and Business Development Officer for Complex Care Solutions, Inc., a private equity backed health information technology company specializing in risk adjustment and care management services for government programs, including Medicare Advantage and Medicaid. She directed and implemented corporate strategy; assuring the continued growth of the company through revenue generating strategies and expansion of new business ventures.
Previously, Ms. Richman was Vice President, Healthcare Business Development and Strategy for Nielsen, responsible for aligning clients’ business strategies with market demands and accretive revenue opportunities.
Ms. Richman has held senior management positions with Baxter International and Caremark International where she was instrumental in designing and implementing managed care, physician practice management, care delivery, health information technology and analytics initiatives.
Ms. Richman has been a national speaker about consumerism and emerging industry trends.
Ms. Richman earned a bachelor’s degree, cum laude, from Herbert H. Lehman College in New York.
Dr. Esteban Pombo-Villar, is Chief Executive Officer of TargImmune Therapeutics, a biopharmaceutical company focused on the development of novel immuno-oncology therapeutics, based in Basel, Switzerland. Previously he was Chief Operations Officer (COO) for Oxford BioTherapeutics, and a Member of their Boards of Directors. Prior to joining Oxford BioTherapeutics, Dr. Pombo-Villar was at Novartis and Sandoz for over 23 years, the last 12 years engaged in Business Development and Alliance Management, and as Head of Alliance Management at the Novartis Institute for Biomedical Research (NIBR). Prior to that he served in several roles as medicinal chemist in the Neuroscience research group. He obtained a PhD, MSc and BSc in organic chemistry from the University of Warwick (UK), was a visiting researcher at the University of Newcastle upon Tyne (UK), and completed postdoctoral studies at the ETH in Zurich. Dr. Pombo-Villar is a Fellow of the Royal Society of Chemistry, member of several scientific societies and has completed executive business studies at IMD (MTE, Lausanne), Harvard Business School (US), and the Tuck School of Business (Dartmouth, US). A native of Bogotá, Colombia, he lives in Switzerland since 1986.
As one of the founders and the current President of Allied Physicians Group, Gary Mirkin, MD, FAAP, is a recognized leader in the physician community. Allied Physicians Group, which was formed approximately ten years ago with approximately 30 physicians, now serves more than 180,000 patients and includes 130 physicians with 30+ offices throughout Long Island, Greater NYC, and the Hudson Valley. In addition to being the largest pediatric group in the country, Allied is recognized by the NCQA as a patient centered medical home.
Under Dr. Mirkin’s leadership, Allied Physicians Group has been recognized for its efforts in promoting wellness initiatives such as breastfeeding, weight loss and nutrition as well as pediatric mental health screening. In particular, his emphasis on early diagnosis of mental health issues through adolescent screening has helped countless young people and teens with depression and other mental health challenges.
In 2015, Allied Physicians Group launched the Allied Foundation, a not-for-profit organization whose mission is to improve the health and well-being of people in the community. Allied Foundation uses a combination of fundraising and program implementation to achieve its mission. Allied Foundation supports:
Breastfeeding in the community. Allied Lactation Consultants are available to help guide every mother reach her personal breastfeeding goal.
Community-wide education. Free lecture series on topics including managing food allergies, ADHD, anxiety and more.
Early childhood literacy. Many locations participate in collect gently used books from their communities to be donated to The Book Fairies and others support Reach Out and Read initaitives.
Dr. Mirkin graduated from The Ohio State University with a B.S. in Microbiology in 1979. He then went on to The Ohio State University College of Medicine, which he completed in 3 years, graduating in 1982. Dr. Mirkin completed his residency in Pediatrics at The New York Hospital-Cornell University Medical Center from 1982-1985. He has been board certified in Pediatrics since 1989, is a fellow of the American Academy of Pediatrics, and has a special interest in dealing with infectious disease and autism. He has been honored with the Healthcare Heroes Physician Hero Award in 2013 as well as a “Top CEO” in 2016 by Long Island Business News.
When he is not working, spending his time as President of Allied and with his patients, Dr. Mirkin enjoys cycling. He has completed the 62 mile Mansion Ride for Autism multiple times and has also completed four NYC Century Bike Tours.
Gregory Solometo co-founded Alliance Homecare in 2006 and serves as the Chief Executive Officer. Gregory oversees the sales and marketing team and is the lead visionary behind the company’s short and long-term strategic initiatives.
Gregory started the company after he took care of his grandmother for five years when she was suffering from Alzheimer’s and created The Grandma RuleTM hiring philosophy. Gregory’s firsthand experience of searching for caregivers showed him that there were limited resources that met his high level of standards of client care and customer satisfaction. Since that time, Gregory has been committed to providing all clients with an elite and highly qualified team of healthcare professionals that exceed industry standards.
Prior to starting Alliance Homecare, Gregory has worked primarily in the financial services industry. Most recently, he worked as a Lean Process Engineer at Deutsche Bank where he provided strategic consulting services to various divisions of the Investment Banking structure and it’s operations in the US and abroad.
Gregory graduated from Emory University in 1995.
President & Co-CEO, then Executive Chairman – MultiPlan, Inc.; CEO – Amalgamated Life Insurance Company; CEO – Urban Community Insurance Company. Harvey has been active on a number of boards (for profit and not-for-profit) including: Chairman – National Cooperative Bank, National Cooperative Business Association and National Association on Drug Abuse Problems; Executive Committee – America’s Health Insurance Plans and Council for Affordable Quality Healthcare; appointed by President Clinton and confirmed by the U.S. Senate to serve on the Board of Directors of the Overseas Private Investment Corporation (OPIC)
Ilan Danieli has served as Precipio's CEO since founding the company in
2011. With over 20 years managing small and medium-size companies,
some of his previous experiences include COO of Osiris, a publicly-traded
company based in New York City with operations in the US, Canada,
Europe; and VP of Operation at Laurus Capital Management, a multi-billion
dollar hedge fund; as well as in various other entrepreneurial ventures. Ilan
holds an MBA from the Darden School at the University of Virginia, and a
BA in Economics from Bar-Ilan University in Israel, and served in the Israeli
military as a tank commander. He is also a private pilot, and while on the
ground, he enjoys travel, scuba diving, skiing (snow and water), and also
dabbles in gourmet cooking.
Jeffrey C. Thrope is a partner and health care business lawyer with Foley & Lardner LLP. Mr. Thrope has a broad range of experience as a general counsel to the health care and related industries, as well as not-for-profit organizations and governments. He is a member of the Health Care Industry Team, as well as the Public Finance Practice.
In addition to his considerable experience in helping public and safety-net hospitals develop operational and financing plans necessary to their survival, Mr. Thrope has provided advice and counsel in virtually every area of health care law, including health care institutional structuring and governance, compliance, network formation, litigation oversight, medical-legal and ethical issues, contracting, high technology acquisition and implementation, Internet and e-commerce activities, bank financing, reimbursement, dispute resolution (including litigation where necessary), labor, internal investigations, physician arrangements and credentialing and related matters. Mr. Thrope was instrumental in developing and implementing structures for the assisted living industry as it expanded into New York.
Mr. Thrope has provided similar services to governments, colleges and other not-for-profit entities in the educational field, and has a particular talent for helping maintain his clients’ mission, while addressing whatever legal issues they face. He has helped governments address structuring and financial issues, and has identified significant revenue and cost containment opportunities that have become more critical in these difficult times.
Prior to joining Foley, Mr. Thrope was a partner at Kalkines, Arky, Zall & Bernstein LLP (1988 to 2002), and then at Manatt, Phelps & Phillips, LLP (2003 to 2009). He was an associate and partner at other firms from (1981-1987).
Mr. Thrope has spoken at various conferences and has contributed to course materials, including the Practicing Law Institute Faculty 1999: Understanding, Preventing and Litigating Year 2000 Issues - Health Care Industry.
Mr. Thrope is a graduate of New York University School of Law (J.D., 1980), where he was a member of the Law Review, and a graduate of Yale University (B.A. 1977).
Mr. Thrope served as a law clerk to the Honorable Leonard B. Sand, Unites States District Court Judge for the Southern District of New York (1980-1981).
Mr. Thrope also has served as a member of the Health Law and Family Courts Committees of the Association of the Bar of City of New York.
Mr. Thrope was admitted to the New York Bar in 1981, and is admitted to practice in the federal courts for the Southern and Eastern Districts of New York and before the Second Circuit Court of Appeals.
A believer in truly big ideas, Ken launched and co-founded Patient Innovations, LLC and created OnTime Care®: cloud-based software to eliminate waiting in Doctor’s offices and optimize both practices and hospitals.
UnitedHealthcare (UHC) partnered with Patient Innovations in 2014 to fund development of OnTime Care®. UHC featured OnTime Care® at its booth at the Consumer Electronics Show in Las Vegas as an emerging new technology that will offer competitive advantage – before the software was even written! Patient Innovations has nine patents pending on several of their innovative solutions.
Ken’s next big idea, and part of the Patient Innovations® suite, is OnTime Discharge™ - software to get you out of the hospital within 15 minutes of the time they tell you you’ll be going home.
Prior to founding Patient Innovations®, Ken’s early career included 22 yeas in retail banking. Ken then co-founded AustinWilliams in 1992, the leading advertising and marketing consultancy headquartered on Long Island. AustinWilliams is the Island’s most-awarded advertising agency, and serves three key verticals: banking, healthcare and higher education.
Ken has always been fascinated by technology and brought AustinWilliams into the digital age in 1995. The agency has been growing its digital business ever since.
Ken is a product of Brooklyn College where he earned a bachelor’s degree in Economics.
He is involved in several charities and trade organizations: YJP (the Young Jewish Professionals), the Long Island Association, Long Island Advancement of Small Business, (LIASB), American College of Healthcare Executives (ACHE), Direct Marketing Association - Long Island Chapter (DMALI), Health Leaders of NY (HLNY), The Beryl Institute and more.
In October 2014, Ken was inducted into the Direct Marketing Association Hall of Fame.
He’s the immediate past President of AJC’s Long Island Chapter, serves on their Board, and also chaired their annual golf outing. Ken is also a member of the New York Board of Regents for the Center for Security Policy and participates in their Victory Coalition briefings.
In 2015 Ken co-founded Alert Long Island, the first downstate New York chapter of ACT for America, the leading grass roots national security organization in the World.
He also serves on the Board of the Long Island Strategic Alliance (LISA) – a consortium of several small business trade groups.
Ken lives in Mount Sinai at the Hamlet Willow Creek – an award-winning golf course… you just can’t tell from his game!
Lawrence Vernaglia is a partner and health care lawyer with Foley & Lardner LLP where he is the department chair for the firm’s Industry Teams Department, responsible for overall strategy and leadership across all industry teams. Prior to that, he served for 8 years as chair of the firm’s Health Care Industry Team and Health Care Practice. Lawrence represents hospitals, health systems and academic medical centers and a variety of other health care providers. Lawrence's practice involves regulatory and transactional matters, including Medicare/Medicaid reimbursement compliance advice and appeals; mergers, acquisitions and financings; state regulatory issues including licensing, change of ownership, and CoN/DoN; survey/certification appeals; fraud & abuse/Stark law analyses; managed care contracting; and general corporate and business planning in health care. He runs strategic planning programs for senior management and governing boards.
Dr. Peter Kash Ed.D/MBA has been in the field of biotechnology for over almost 30 years helping fund more than a dozen biopharmaceutical companies several with FDA approvals. Currently, he is Managing Director at Castle Hill Capital Partners and Vice-Chairman of TargImmune Therapeutics AG.
Besides a BS in Management Science and an MBA in Finance he also holds a Doctorate in Education from the Azrieli School of Yeshiva University. He has served as an adjunct Professor of Entrepreneurship at the Wharton School of Business, and has been a Visiting Professor at Nihon University in Tokyo Japan and in 2015 as a Visiting Professor at Hebrew University in Jerusalem. He has authored several books distributed in more than 30 countries, his most recent release is Take Two Tablets Medicine from the Bible.
Rami founded Telesofia Medical (MyOp.md), combining his passions to medicine and technology.
He has over 17 years of experience in the Internet industry. He started his career in 1997 at ICQ (formerly Mirabilis, acquired by AOL in 1998, for US$407 million) in various roles including Director of Web Operations. Since 2001, he helped several companies and start-ups with product development, launching and marketing in the online world. As VP Operations at Novawind, he provided Hands-On marketing, business development and innovation management services for leading companies.
Rami also holds a medical doctor degree from the Tel Aviv University, and worked at the Vascular Surgery department in Tel-Aviv Sourasky (Ichilov) Medical Center and Assaf Harofeh Medical Center.
Torrey K. Young is a health care lawyer with Foley & Lardner LLP. She focuses on health care regulatory compliance and transactional matters for hospitals, academic medical centers, laboratories, home health agencies, hospice companies, and many other health care providers. Torrey has significant experience conducting internal investigations, responding to False Claims Act claims, providing fraud and abuse/Stark law analyses, and advising on Medicare/Medicaid reimbursement issues. She is a member of the firm’s Health Care Industry Team and the Government Enforcement Defense & Investigations Practice.
Featuring speakers from the hospital, insurance, biotech, pharma, medical device, medtech, senior living, and home care sectors, this event will bring together top executives from across the healthcare spectrum to discuss the current and future market trends that we are seeing in the industry.The breakout sessions, featuring our signature YJP format for maximum interaction and value, will focus on topics such as:
-The Future of Post-Acute Care
-Investing in Healthcare
-Positioning Your Organization for the Future
-Advances in Immuno-Oncology
-Transitioning to Value-Based Care
...and many more!Join us for two days of stimulating conversation, gourmet food and drink, and high-level networking with the top names in healthcare.
The YJP Organization is the world largest group of business leaders, executives and investors to provide mentoring leadership opportunities for the new generation of Jewish business leaders.Interested in speaking? Please contact Michelle - email@example.com
Interested in sponsoring? Please contact Gabrielle - firstname.lastname@example.org
This event starts on February 11th at 4:00 PM.